WO2005003366A1 - A method for the production of bacterial cellulose - Google Patents

A method for the production of bacterial cellulose Download PDF

Info

Publication number
WO2005003366A1
WO2005003366A1 PCT/PL2004/000051 PL2004000051W WO2005003366A1 WO 2005003366 A1 WO2005003366 A1 WO 2005003366A1 PL 2004000051 W PL2004000051 W PL 2004000051W WO 2005003366 A1 WO2005003366 A1 WO 2005003366A1
Authority
WO
WIPO (PCT)
Prior art keywords
cellulose
culture
medium
parts
production
Prior art date
Application number
PCT/PL2004/000051
Other languages
French (fr)
Inventor
Stanislaw Bielecki
Alina Krystynowicz
Wojciech Czaja
Marek Kolodziejczyk
Original Assignee
Politechnika Lodzka
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Politechnika Lodzka filed Critical Politechnika Lodzka
Priority to EP04748875A priority Critical patent/EP1660670A1/en
Publication of WO2005003366A1 publication Critical patent/WO2005003366A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/04Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28Polysaccharides or their derivatives

Definitions

  • the subjects of the present invention are a method for the production of bacterial cellulose, a method of immobilising the bacteria Bacillus subtilis, synthesizing a protease, a method for the production of immobilised biocatalysts, an application of bacterial cellulose produced in a stationary culture of an Acetobacter xylinum strain as a wound dressing, a method of modifying cellulose membranes in order to produce wound dressings.
  • the present invention relates to the synthesis of cellulose which forms a gelatinous, elastic membrane on the surface of a liquid medium in stationary conditions.
  • the present invention also relates to the application of bacterial cellulose as a carrier for the production of immobilised biocatalysts, as well as a method for the application of bacterial cellulose as a wound dressing in the treatment of extensive 1, 2 and 3 degree burns and surgical incisions, which is used in the form of cellulose membranes of arbitrary size and shape.
  • the subjects of the present invention are used in the production of wound dressings in the form of cellulose membranes of arbitrary size and shape.
  • Cellulose is an unbranched homopolysaccharide, composed of ⁇ -D-glucopyranose units connected by ⁇ -l,4-glycosidic bonds.
  • Bacterial cellulose is a highly crystalline cellulose, with a high I ⁇ [33; 10] fraction content.
  • the glucan chains synthesized by bacteria bind to form elementary cellulose sub-fibrils some 1,5 nm wide These are some of the thinnest naturally appearing fibrils, comparable only with the elementary cellulose fibrils discovered in the cambium of some plants, and the mucus from Cydonia oblonga [18].
  • Bacterial cellulose is synthesized by several genera of bacteria, of which the best known are strains of the vinegar-producing genus Acetobacter.
  • the synthesis of type and cellulose by Acetobacter xylinum, as well as by other organisms capable of it, is composed of at least two stages: 1) polymerisation of glucose molecules to form a linear ⁇ -1,4 glucan, 2) and the binding and crystallisation of individual polymer chains to form larger structural units.
  • Electron microscopy of negative-stained cellulose produced by an Acetobacter xylinum [14] culture has shown the hierarchic character of spatial cellulose accumulation. Firstly, 10-15 ⁇ -l,4-glucan chains form a subf ⁇ bril some 1,5 nm wide. The subfibrils bind and form microf ⁇ brils (3,0- do 3,5 nm) composed of numerous parallel chains.
  • citrate Among other carbon compounds used in this process, citrate, gluconate and lactate should be mentioned. Geyer et al. [7] showed that citrate can me metabolised by Acetobacter, but only when the medium contained both citrate and glucose, where the latter will be utilised first, and the citrate after it has been depleted. It was also noted that citrate has a beneficial effect on the synthesis of cellulose. Other authors indicate gluconates as one of the possible carbon sources in cellulose [13]. Masaoka et al. [19] show that gluconates accumulated in the medium, up to a concentration of 20 g/1, were utilised by the bacteria. Matsuoka et al.
  • lactate (0.15% v/v) added to a medium containing fructose, yeast extract and peptopne as a nitrogen source, exhibits a stimulating effect on the production of bacterial cellulose.
  • mixed cultures were maintained, containing bacteria producing acetic acid and lactic acid. The best results were obtained using strains of Lactobacillus, Leuconostoc and Pediococcus. These bacteria were also cultured in the presence of the yeast Sacharomyces in order to hydrolyse saccharose using ⁇ -fruktofiiranosidase.
  • This method helps increase the efficiency of BC synthesis, because after 14 days of mass culture some 8,1 g cellulose were obtained from 1 litre of medium, as compared to thr 6,4 g/1 obtained without using Lactobacillus [31]. Ethanol may also be one of the stimulating factors of BC synthesis [21].
  • the results from a continuous culture of Acetobacter xylinum using a medium containing fructose and ethanol show that an ethanol concentration of 10 g/1 significantly increases BC synthesis efficiency, whereas at 15 g/1 it is inhibitory. Based on these results, it may be surmised that just as for lactate, the ethanol acts as a source of energy accumulated as ATP, and is not a substrate for cellulose synthesis.
  • ATP activates fructokinase, and inhibits glucose-6-phosphate dehydrogenase, thereby inhibiting the conversion of 6-phosphoglucose to 6- phosphogluconates. It was also noted that the addition of ethanol to the culture medium helped prevent the spontaneous mutation of the Acetobacter sp. A9 strain into the Ce ⁇ form, which is incapable of synthesizing cellulose. The precise mechanism driving this phenomenon is not understood, however. Research into the effects of vitamins on BC synthesis has shown that the best stimulators are pirydoxin, nicotinic acid, p-aminobenzoic acid, and biotin [12, 20]. Fontana et al. [5] successfully used plant extracts, particularly from black tea, which contained components which stimulate cellulose synthesis.
  • Bacterial cellulose biosynthesis can be maintained both in stationary cultures and in liquid mass cultures. Generally, the selection of the method to be employed is dependent upon the planned use of the synthesized polymer [16]. The control over the process is greatly complicated in a stationary culture by a membrane which forms on the surface of the medium, which in turn limits access to the medium.
  • BC synthesis in stationary conditions can occur using a single-step procedure (a medium inoculated with a 5-10% inoculate) or a two-step procedure [2]. The latter also includes a liquid culture stage in order to amplify the biomass, and then a continuation in a stationary culture [22].
  • Ce ⁇ a culture's instability characterised by a tendency for the strains to spontaneously mutate into inactive forms.
  • An unstable strain can be successfully used in a stationary culture, in which bacterial growth and cellulose synthesis occurs at the air-medium phase border. Ce ⁇ cells are favoured in a shaken culture, in which the growth of Cet bacteria is limited by the rate of oxygen dissolution and cell aggregation by the synthesized cellulose (which limits oxygen access).
  • Bacterial cellulose may also be produced in a continuous stationary culture [26]. Acetobacter xylinum cells are in this case cultured on trays, on SH medium.
  • the cellulose membrane produced on the medium's surface is continuously fed into a bath in a solution of sodium dodecyl sulphate (SDS) in order to inactivate the cells, and is then rolled onto a special roller.
  • SDS sodium dodecyl sulphate
  • This process was maintained for several weeks, at a rate of 35 mm/h, and periodic replenishment of the medium (every 8-12 hours), in order to maintain optimal culture conditions. In this way, a 5 m long cellulose belt was produced which indicates the possible utility of this method in industrial processes.
  • Another described method of cellulose synthesis is an Acetobacter culture in horizontal bioreactors equipped with w rotating rollers, on which the produced polymer accumulated [27].
  • Bacterial cellulose has great utility in medicine, particularly as a wound dressing and for artificial organs. This is due to properties such as being highly crystalline, high mechanical strength, an ability to absorb fluids, and excellent histocompatibility with living tissue, particularly with blood, specially purified cellulose membranes produced in a stationary culture may be a ready wound dressing, which meets all standards for modern dressing materials [17, 5]. It is biocompatible, porous, elastic, easy to apply and easy to store. It maintains optimum moisture during the healing of a wound, and may be sterilised using high temperature.
  • Patent descriptions PL 171952 (published 1995.02.06) and application P-317139 (submitted 1996.11.20) relate to a method of producing bacterial cellulose membranes through a surface culture of Acetobacter xylinum, on a glucose-based medium.
  • This solution is based on the isolated Acetobacter xylinum strain P23, of the genus Acetobacter, a typically aerobic species characterised in its ability to produce acids from an incomplete oxidation of carbohydrates and alcohols, which exists as oval rods, singly or doubly or arranged into chains, and has an optimal growth temperature of 28-30°C at a pH of 4 -6.5 on solid media containing glucose, yeast extract, peptone, and agar. In liquid media, it forms a dense mucuslike membrane.
  • the acids it produces as temporary or terminal products are released into the culture environment.
  • the isolated Acetobacter xylinum P23 strain is incubated in a liquid medium.
  • a method according to the present invention produces cellulose membranes containing 90 - 97% ⁇ -cellulose. Membranes produced by this method may be used as a dressing in surgery and dermatology.
  • Patent description US5472859 (published in 1995.12.05) describes a method for the enzymatic production of new forms of cellulose and another for in vitro. In the first method, cellulose is synthesized in a reaction catalyzed by endoglucanase, in the presence of an active form of saccharide substrate in an organic solvent environment.
  • the second method relates to the synthesis of cellulose in a reaction catalyzed by glycosyl transferase, in the presence of UDPG, in an aqueous environment in conditions conducive to polymerisation and crystallisation of parallel glucan chains from the enzyme/mycelle complex.
  • US4863565 (published in 1989.09.05) present a solution relating to the production of bacterial cellulose in a shaken environment, in which over 70 h at least OJg/L was produced.
  • Patent description US5955325 presents a solution relating to microbiological cellulose with a high water content, produced in a disc fermenter.
  • Patent description EP0792935 presents a process of cellulose production in a fermenter, at a CO 2 partial pressure of 10.13 kPa (0J0 atm) or less in the gaseous phase of the fermenting chamber.
  • Patent description JP54041321 presents a method for the production of a dressing for skin lesions, which has excellent local adherence and long-term activity, using hydroxypyrocellulose and polyacryllic acid salts and their active ingredient.
  • Patent description EP0918548 presents a solution relating to the application of oxidized cellulose, preferentially oxidized regenerated cellulose (ORC) and their complexes with proteins such as collagen, in order to provide a protective dressing for chronic wounds.
  • Patent description WO8602095 (published 1986.04.10) relates to a method of producing a cellulose film as an artificial skin to be used in grafting. The method of producing the cellulose film encompasses the preparation of a culture medium, in which the nutrient media are nitrates and carbohydrates, which is inoculated with Acetobacter xylinum.
  • Patent descriptions US4788146 (published 1988.11.29), and US4588400 (published 1986.05.13) relate to the application of cellulose membranes as dressings for wounds and abrasions, as well as thermal wounds. They are produced in a culture of Acetobacter xylinum, to a thickness of 0J do 15 mm or more and are sterilised following removal, while they are still highly hydratated.
  • the goal of the present invention is to provide the means which could be used to synthesise bacterial cellulose, and to obtain it for the production of wound dressings possessing certain, defined qualities determined by their intended usage.
  • the subject of the present invention is a method for the production of bacterial cellulose, characterised in that a culture of Acetobacter xylinum is maintained on an appropriate medium for the production of a cellulose surface membrane, which is then separated from the culture liquid, and further purified.
  • this process encompasses after the further purification the sterilisation process.
  • this process encompasses the initial culture phase, as well as the proper production phase.
  • this process encompasses the initial culture phase, in which the culture medium is inoculated with Acetobacter xylinum bacteria and they are cultured to achieve a density of ca. 5x10 7 cfu/ml, and then this inoculum is used to inoculate the production culture.
  • the culture medium is characterised by the following composition by weight: 10 - 30 parts glucose, 2.5 - 12.5 parts yeast extract, 2.5 - 12.5 parts peptone, 1.25 - 6.25 parts MgSO 4 x 7H 2 O, 1.25 - 7 parts Na 2 HPO 4 , 0.5 - 3 parts citric acid, 5 - 100 parts ethanol to 1000 parts distilled water.
  • the culture medium used in the initial culture is inoculated with 5 - 10%o (v/v) of the inoculum.
  • the method of preparing the inoculum consists of inoculating culture medium with a bacterial culture at an amount of 5 - 10%, maintained in this medium at maximum 48 h, at a temperature of 27-33°C.
  • the bacterial suspension is used to inoculate the production medium.
  • the inoculated medium is preincubated in the bioreactor.
  • the preincubation of the inoculated medium is performed with constant shaking.
  • the inoculated medium is preincubated up to 24 h at a temperature of 27 -33°C.
  • the inoculated medium is thoroughly mixed and poured into the bioreactor, and cultured for 5-10 days.
  • the proper production culture is maintained without shaking.
  • the membranes produced are removed and thoroughly purified.
  • the membranes produced are thoroughly cleaned, by rinsing in water, by boiling in a 1 - 3% NaOH solution for 0.5 - 2 hours, rinsing again to remove all traces of
  • the membranes produced are rolled, pressed, and wringed, to remove excess water, packed into sealed foil and sterilized by irradiation, using doses of 20 - 25 kGy.
  • the carbon source in the production medium for the synthesis of bacterial cellulose is a byproduct of industrial production of glucose.
  • the composition of the production medium for the synthesis of bacterial cellulose is based on byproduct constituents of plant origin.
  • the process encompasses preparing the production medium for the synthesis of bacterial cellulose, in which the carbon source is byproduct material containing 45 - 70% glucose, 10 - 15% isomaltose, 5 - 6 gentiobiose or glucose-fructose syrup (1:1) or molasses containing 40 - 60% saccharose and glucose from 5 - 25% or the effluent from the dextran microbiological synthesis.
  • the carbon source is byproduct material containing 45 - 70% glucose, 10 - 15% isomaltose, 5 - 6 gentiobiose or glucose-fructose syrup (1:1) or molasses containing 40 - 60% saccharose and glucose from 5 - 25% or the effluent from the dextran microbiological synthesis.
  • the effluent from the microbiological synthesis of dextran contains 10 - 15% fructose, 0.05 - 2% glucose and 1 - 6%> saccharose or glycerol.
  • the nitrogen source in the culture medium is corn steep liquor.
  • yeast extract and 3 - 5 parts peptone from the culture medium are replaced with 15 - 25 parts of corn steep liquor.
  • the liquid following the end of culturing is reused to produce the medium.
  • the culture medium is supplemented with 3 - 8 parts carboxymethylocellulose
  • CMC CMC with a molecular mass between 90.000 - 250.000.
  • the 3 - 5 parts yeast extract and 3 - 5 parts peptone from the culture medium are replaced by introducing the inoculate liquid as a nitrogen source.
  • the cellulose biosynthesis in the stationary culture is maintained in such conditions, that the S/N ratio (bioreactor surface/volume) is 0.5-0.9 cm "1 .
  • the subject of the present invention is a method of immobilising Bacillus subtilis bacteria, characterised in that the immobilisation carrier is a mixture of polyvinyl alcohol (PNA) with a mass of 72000, at a concentration of 10 - 12% and pulverised bacterial cellulose at 0J2 -
  • PNA polyvinyl alcohol
  • the mixture is cryo-gelled into spherical forms through repetitive freezing at temperatures between— 17 and -25°C and defrosting at ca. 20°C, in vegetable oil.
  • the subject of the present invention is a method of producing immobilised biocatalysts, characterised in that the bacterial cellulose synthesized by the isolated strain of Acetobacter xylinum, P 3 o, belonging to the genus Acetobacter, in a stationary culture, is used to produce a carrier to immobilise the yeast Saccharomyces cerevisiae and the bacteria Bacillus subtilis.
  • the bacterial cellulose is synthesized in a liquid medium containing 10 - 30 parts glucose, 10 - 30 parts com steep liquor, 5 - 15 parts ethanol, at a temperature of 27 -
  • the subject of the present invention is an application of bacterial cellulose produced in a stationary culture of an Acetobacter xylinum strain as a wound dressing, particularly for bums and surgical wounds.
  • the bacterial cellulose is used in the form of cellulose membranes of arbitrary shape and size.
  • dressings made of bacterial cellulose secure the surface of wounds against excessive extranefrous water loss.
  • bacterial cellulose dressings ensure a moist environment and seal the surface of the wound.
  • the modified cellulose material is used.
  • the subject of the present invention is a method of modifying cellulose membranes, characterised in that it consists of selective oxidation of bacterial cellulose using oxidative agents.
  • the cellulose membranes are produced in the presence of CMC.
  • the subject of the present invention is a method of modifying cellulose membranes, characterised in that it consists of the saturating the membrane with a solution of 1-6 % glycerol, 0.5 - 4 % PEG 400, 0.01 - 1 % chlorohexidine.
  • the subject of the present invention is a method of modifying cellulose membranes, characterised in that it consists of the production of composites consisting of cellulose and monomers and/or polymers and/or nanofibres and/or textiles during culturing.
  • the composite is the additional binding agent for bioactive substances promoting healing.
  • the composite increases the pressure applied to the wound.
  • the composite elongates the drying-out time of the dressing.
  • Figure 1 shows a deep 2b bum of moderately thick skin of the forearm, hand and fingers of the right hand with the cellulose dressing.
  • Figure 2 shows the application of a cellulose dressing. The dressing covers all of the back of the neck, back and loin area.
  • the PI inoculation medium containing the following constituents by mass: 20 parts glucose, 5 parts yeast extract, 5 parts peptone, 2.5 parts MgSO 4 x7H O, 2.7 parts Na 2 HPO , 1J5 parts citric acid, 10 parts of ethanol, to 1000 parts distilled water; is inoculated with 5% (v/v) of a suspension of Acetobacter bacteria (5x10 7 units/ml) maintained in that medium no longer than 7 days, at a temperature of 4°C. It is incubated for 2 days at a temperature of 30°C, when, following intensive mixing, the suspension is used to inoculate production medium of the same composition at a rate of 5% of production medium volume.
  • the whole volume is then preincubated for 24 h at a temperature of 30°C, and it is then transferred into bioreactors of an appropriate volume, such that the S/N ratio (surface/volume) is 0.7 cm "1 .
  • bioreactors of an appropriate volume, such that the S/N ratio (surface/volume) is 0.7 cm "1 .
  • 14 dm 3 of culture medium is prepared, which following inoculation and preincubation is used to maintain the production culture proper in the bioreactor in stationary conditions over 7 days, whence the 5mm thick membranes formed are cleaned with tap water. They are then treated with 1% ⁇ aOH at a temperature of 100°C, for 1 hour, again rinsed in tap water, and then treated with l%acetic acid, once again in tap water, and finally in distilled water.
  • Example 1 An inoculate obtained as per Example 1 was used to inoculate sterile production medium composed of the following by mass: effluent from glucose crystallisation in an amount corresponding to 2% glucose, 20 parts maize mash and 10 parts ethanol in 1000 parts distilled water. Then, the procedure was as per Example 1 and as a result a mass of cellulose comparable to Example 1 was obtained.
  • Example 3 An inoculate obtained as per Example 1 was used to inoculate sterile production medium containing as a carbon source glucose-fructose syrup (1:1) in an amount corresponding to 1% glucose and 1% fructose and the remaining components like in medium PI. Then, the procedure was as per Example 1 and as a result a mass of cellulose ca. 15% higher than in Example 1 was obtained.
  • Example 1 An inoculate obtained as per Example 1 was used to inoculate sterile production medium, in which the fructose source utilised was 50 parts by mass of fructose effluent, a byproduct of separation of dextrans from a Leuconostoc mesenteroides culture and 2 parts ethanol and 5 parts of yeast extract, and distilled water to 1000 parts. Then, the procedure was as per Example 1 and as a result a mass of cellulose ca. 20% higher than in Example 1 was obtained.
  • Example 1 An inoculate obtained as per Example 1 was used to inoculate sterile production medium, in which the carbon source was molasses in an amount such that the saccharose contained therein amounted to 50 parts by mass, and 5 parts yeast extract as the nitrogen source, 10 parts ethanol, and distilled water to 1000 parts. As a result a mass of cellulose ca. 75% of the mass of cellulose from Example 1 was obtained.
  • Example 7 An inoculate obtained as per Example 1 was used to inoculate sterile PI production medium, in which 5 parts of yeast extract and 5 parts peptone were replaced with 20 parts maize mash, not altering the remainder of the components. Then, the procedure was as per Example 1 and as a result a mass of cellulose ca. 10% higher than in Example 1 was obtained.
  • Example 7 An inoculate obtained as per Example 1 was used to inoculate sterile PI production medium, in which 5 parts of yeast extract and 5 parts peptone were replaced with 20 parts maize mash, not altering the remainder of the components. Then, the procedure was as per Example 1 and as a result a mass of cellulose ca. 10% higher than in Example 1 was obtained.
  • Example 7 An inoculate obtained as per Example 1 was used to inoculate sterile PI production medium, in which 5 parts of yeast extract and 5 parts peptone were replaced with 20 parts maize mash, not altering the remainder of the components. Then, the procedure was
  • Example 1 An inoculate obtained as per Example 1 was used to inoculate sterile PI production medium, in which 50% was liquid from a 7 day culture. Then, the procedure was as per Example 1 and the results were comparable to Example 1.
  • Example 1 An inoculate obtained as per Example 1 (10% v/v) was used to inoculate sterile PI production medium, which was missing yeast extract and peptone, leaving the other components unchanged.
  • the nitrogen source in this case was contained in the inoculate sample, 100 parts by weight.
  • the procedure was as per Example 1 and as a result a mass of cellulose ca. 70% of the mass from Example 1.
  • the membrane produced in these conditions was white and more clear, which made the purification process much less labour intensive.
  • Example 9 The effect of CMC on the mass of produced cellulose membranes
  • the bacteria were cultured for 7 days on a modified SH medium, containing an addition of 1% ethanol and 0.05% MgSO x7H 2 O, at a temperature of 30°C, in 500 ml Erlenmeyer flasks containing 100 ml of medium enriched with 1.0% CMC1 (90.000) or CMC2 (250.000).
  • the membranes produced during this period were air-dried to a solid, dry mass, which varied between 0.55 g depending on the degree of CMC polymerisation.
  • the masses of the membranes produced were, respectively, 0.55 g, whereas they were 0.31 g without CMC or 0.50 g with CMC2.
  • Example 10 0.12% of bacterial cellulose powder is added to a 10% polyvinyl alcohol solution
  • biopreparation samples obtained as per Example 10 undergo triple rinsing in 30 min, using 1 ml aliquots of physiological saline.
  • the suspension of released bacteria is swabbed onto medium solidified with agar, and counted after 24 h of culture at 37°C.
  • 10 times less bacteria were released than from the sample without cellulose.
  • Immobilised biopreparations produced as per Example 10 are used in the biosynthesis of proteolytic enzymes, introducing 4% of biocatalyst into 50 cm 3 of sterile culture medium and incubating it at 30°C, for 66 h, constantly mixed at 220 rpm.
  • the culture cycle was repeated 3 times using the same biopreparations, following washing with physiological saline. In each case the serine protease activity was 17% higher when the preparation contained bacterial cellulose.
  • the culture is continued for the next 4 hours, after which the suspension of cellulose along with adsorbed yeast cells is separated from the medium, and following thorough a wash, used in the process of saccharose hydrolysis, using a 5% saccharose solution and the biopreparation at a ratio of 1 :5 by weight.
  • One cycle lasted 10 hours, and there were 10 cycles.
  • Example 12 The cellulose membrane obtained as in Example 6 was initially ground, and then particles 2-3 mm in diameter were homogenized at 13000 ⁇ m. The pulp obtained was centrifuged at 5000 ⁇ m. and the wet mass was added at a rate of 10% to a 2% sodium alginate solution, lg of wet yeast pulp was introduced into 20 cm 3 of this mixture, thoroughly mixed, and dripped into an ice-bath chilled 2%> CaCl 2 solution, with constant mixing. The spherical portions of the biopreparation were kept in the 2% CaCl 2 solution at a temperature of 4°C for 12 hours. The produced biopreparation was used for continuous saccharose hydrolysis, using a 50% solution thereof.
  • the process took place in a vertical reactor at a temperature of 40°C, with a 0.04 cm 3 /min substrate flow-through rate. After 30 days, the saccharose inversion was 80% when the carrier contained cellulose and 65% when it did not. This biopreparation was also used in the hydrolysis of 50% saccharose, using a periodic method of 6 cycles of 8 hours, and the preparation at 1 g per 18 g substrate. In every cycle, the degree of saccharose inversion was 25-30% higher using the biopreparation with the cellulose carrier, than when a non-cellulose carrier was used..
  • Example 13 A cellulose membrane prepared as per Example 6, after 90% of the water was removed, was used in the form of a circle 10 cm in diameter to filter samples of apple juice, using a vacuum filter apparatus.
  • 100 cm 3 of juice was supplemented by 0.5 ml of 1% gelatine solution, and 0.5 ml 3% solution of siliconic acid, and then filtered through a filter containing Hyflo Super Cel diatomaceous earth.
  • the filtered juices were subjected to stability testing by heating to a temperature of 80°C, chilling, and f eezing to -18°C for one hour, and then defrosted at room temperature.
  • the comparative analysis is presented in Table 1.
  • the juice clarified via the cellulose membranes was characterised by a higher clarity before and after the stability test, when compared to the control. Following the stability assay, the juice samples filtered through the membranes exhibit a higher colour intensity.
  • Example 14 Using a culture medium like in Example 6, Acetobacter xylinum were cultured in a bioreactor 100x15x8,5 cm, which dimensions corresponded to the UF filtration module from Amicon for an RA 2000 device. The purified membrane, following removal of 90% of its water, was used as a filtration module to filter wine which exhibited a secondary, opalescent haze. The obtained samples of wine retained full clarity during the 6-month study period, maintained at room temperature.
  • Example 15 Using a culture medium like in Example 6, Acetobacter xylinum were cultured in a bioreactor 100x15x8,5 cm, which dimensions corresponded to the UF filtration module from Amicon for an RA 2000 device. The purified membrane, following removal of 90% of its water, was used as a filtration module to filter wine which exhibited a secondary, opalescent haze. The obtained samples of wine retained full clarity during the 6-month study period, maintained at room temperature.
  • Example 15
  • Cellulose membranes produced according to Example 9 in the presence of 0.5% CMC with a m.m. of 90000 were purified, and dried at a temperature of 37°C. Following 3 hours of drying, the membrane produced in the presence of CMC lost ca. 17% of its water, whereas without CMC it lost 23%, and following 22 hours this was respectively 92,5% and 99%.
  • Membranes oxidized under conditions described in Example 17 were immersed in a 0.02% lysozyme solution, with an activity of 16800 U/mg, for 4 hours, at room temperature, and shaken at 100 ⁇ m. They were then washed with distilled water to rinse away any unbound protein. Compared with unmodified cellulose, oxidized cellulose binds about 2 times as much protein, meaning ca. 60%>.
  • Example 20 The cellulose membrane according to Example 1, was purified and excess water was removed (to 50% of initiall mass). It was then soaked in a solution containing 0,1% chlorohexidine, 6% glycerol, 4% PEG 400. The resulting material retained its elasticity following drying at room temperature, did not cling to skin, was easy to remove without need of prior moistening, and moreover exhibited bacteriocidal properties.
  • Example 20 The cellulose membrane according to Example 1, was purified and excess water was removed (to 50% of initiall mass). It was then soaked in a solution containing 0,1% chlorohexidine, 6% glycerol, 4% PEG 400. The resulting material retained its elasticity following drying at room temperature, did not cling to skin, was easy to remove without need of prior moistening, and moreover exhibited bacteriocidal properties.
  • Example 20 The cellulose membrane according to Example 1, was purified and excess water was removed (to 50% of initiall mass). It was then soaked in a solution containing 0,1% chlor
  • sterile material i.e. cotton cloth
  • cellulose dressings to treat surgical incisions and burns in animals 40 female Wistar rats were used as experimental animals, aged 8-10 weeks with body masses ranging from 152 to 190g ( average 178g). The animals were divided into 4 groups of 10: Group A - rats with a surgical incision treated without dressing Group B - rats with a surgical incision treated with a cellulose dressing Group C - rats treated with a burn treated without dressing
  • the wound surface was an area of 2x3cm. Such a wound surface comprises from 1,9% to 2,5% (on average 2%) of body surface. In the case of bums, such a wound is considered light.
  • the wounds were located on the dorsal side of the animal, below the shoulder blades.
  • sterile cellulose patches were used according to Example 1.
  • One hour prior to the treatment the animals were pre-medicated and then following depilation a surgical wound was produced by removing a patch of skin with a scalpel, to its complete depth, or by producing a bum wound through the application of a steel plate 19x28xlmm heated to 500°C. This method rendered a III degree bum with a surface of 2x3 cm.
  • the wound in group A was left to heal without a dressing.
  • group B cellulose dressings were used, exchanged every alternate day.
  • the burns in group C were treated without dressings.
  • dressings were used as in group B.
  • a plaster cast was put on their torso. After treatment, the animals were kept in individual cages. They received an analgesic in their water and standard feed.
  • Experimental group pressA encompassed 41 patients hospitalised at the Centre for Bum Treatment in Siemianowice Sla ⁇ skie, from the first day following IIA, IIB and/or III degree skin burns to 9-18% of the entire body surface area, of both sexes, aged 18-70 years old. These patients were diagnosed free of colagenosis, diabetes, uraemia, malignant tumours and were never treated with cytostatic drugs, radiation, immunosuppression and had not received blood or blood product transfusions. The local treatment of the bum consisted of applying dressings of bacterial cellulose in 10-day cyclesafter cleaning and disinfecting the burned surface. The cellulose membranes were produced according to Example 1 and sterilised through irradiation.
  • Control groupistB was composed of 12 patients selected according to the same criteria as above, locally treated according to standard methods, using dressings of 3% Braunol, 3% boric acid solutions, and salicylate paste in 10 day cycles. Following cleaning and local preparation of the wound, both groups were treated with (depending on medical indication) a skin graft of moderate thickness.
  • the Parcland crystalloid rule was applied during the first day of hospitalisation, and as of the second day, systemic water loss was measured using the haematocrit.
  • the 10 day treatment observation cycle allowed to repeat until such time as the wound was fit for an autogenic skin transplant of moderate thickness. Graft healing was evaluated and documented photographically during the 2 nd , 7 th and 12 th day following the operation. The number of 10 day intervals of preparatory treatment were determined, as was the total time of healing for the wound covered with the graft.

Abstract

The subjects of the present invention are a method for the production of bacterial cellulose, a method of immobilising the bacteria Bacillus subtilis, synthesizing a protease, a method for the production of immobilised biocatalysts, an application of bacterial cellulose produced in a stationary culture of an Acetobacter xylinum strain as a wound dressing, a method of modifying cellulose membranes in order to produce wound dressings. In general, the present invention relates to the synthesis of cellulose which forms a gelatinous, elastic membrane on the surface of a liquid medium in stationary conditions. The present invention also relates to the application of bacterial cellulose as a carrier for the production of immobilised biocatalysts, as well as a method for the application of bacterial cellulose as a wound dressing in the treatment of extensive 1, 2 and 3 degree burns and surgical incisions, which is used in the form of cellulose membranes of arbitrary size and shape. The subjects of the present invention are used in the production of wound dressings in the form of cellulose membranes of arbitrary size and shape.

Description

A METHOD FOR THE PRODUCTION OF BACTERIAL CELLULOSE
The subjects of the present invention are a method for the production of bacterial cellulose, a method of immobilising the bacteria Bacillus subtilis, synthesizing a protease, a method for the production of immobilised biocatalysts, an application of bacterial cellulose produced in a stationary culture of an Acetobacter xylinum strain as a wound dressing, a method of modifying cellulose membranes in order to produce wound dressings. In general, the present invention relates to the synthesis of cellulose which forms a gelatinous, elastic membrane on the surface of a liquid medium in stationary conditions. The present invention also relates to the application of bacterial cellulose as a carrier for the production of immobilised biocatalysts, as well as a method for the application of bacterial cellulose as a wound dressing in the treatment of extensive 1, 2 and 3 degree burns and surgical incisions, which is used in the form of cellulose membranes of arbitrary size and shape. The subjects of the present invention are used in the production of wound dressings in the form of cellulose membranes of arbitrary size and shape. Cellulose is an unbranched homopolysaccharide, composed of β-D-glucopyranose units connected by β-l,4-glycosidic bonds. Bacterial cellulose (BC) is a highly crystalline cellulose, with a high Iα [33; 10] fraction content. The glucan chains synthesized by bacteria bind to form elementary cellulose sub-fibrils some 1,5 nm wide These are some of the thinnest naturally appearing fibrils, comparable only with the elementary cellulose fibrils discovered in the cambium of some plants, and the mucus from Cydonia oblonga [18]. Bacterial cellulose is synthesized by several genera of bacteria, of which the best known are strains of the vinegar-producing genus Acetobacter. The synthesis of type and cellulose by Acetobacter xylinum, as well as by other organisms capable of it, is composed of at least two stages: 1) polymerisation of glucose molecules to form a linear β-1,4 glucan, 2) and the binding and crystallisation of individual polymer chains to form larger structural units. Electron microscopy of negative-stained cellulose produced by an Acetobacter xylinum [14] culture has shown the hierarchic character of spatial cellulose accumulation. Firstly, 10-15 β-l,4-glucan chains form a subfϊbril some 1,5 nm wide. The subfibrils bind and form microfϊbrils (3,0- do 3,5 nm) composed of numerous parallel chains. In the next stage, 50-80 micrifibrils bind into loose structures 40-60 nm wide, known as ribbons, which contain around 1000 individual glucan chains [8]. Biochemical analyses of the regulatory mechanism of cellulose synthesis have shown that cellulose synthase activity is allosterically activated by the presence of an effector, the cyclic nucleotide, diguanylic acid monophosphate (c-di-GMP) [25]. Wong et al. [34] and Ben Bassat et al. [1] proved, that the biosynthesis of bacterial cellulose is related to the activity of four genes, bcsA (2261 base pairs), bcsB (2405 base pairs), bcsC (3956 base pairs) and bcsD (467 base pairs), which form the cellulose synthase operon 9217 base pairs long. The functions of the proteins coded by each of these genes have not been fully explained yet, but some information has been acquired pertaining to their potential roles, using the complementary method in a damaged cellulose synthase gene [34]. An analysis of the gene coding the catalytic subunit (cesA), analogous to the gene bcsB [34; 1], was also presented by Saxen et al. [28], who then [29] identified the gene coding the regulatory subunit (cesB). However, the work of Saxen [28, 29] showed that the positions of the first two genes in the cellulose synthase operon are precisely opposite to that demonstrated by Wong et al. [34], suggesting that the first of these genes codes the catalytic subunit of cellulose synthase. The functions of the expression products of bcsC a d bcsD have not been fully explained as of yet. Industrial-scale BC production is still limited, primarily due to difficulties in the selection of highly active strains, capable of the biosynthesis of cellulose in large cultures and lacking the ability to metabolise glucose to gluconic acids, as well as due to the relatively high costs of the culture medium. Selection of strains characterised by high BC productivity was performed using traditional screening, through activity determination in monocultures. In their research, Toyosaki et al. [32] isolated 2096 Acetobacter strains from a large variety of plant samples, (fruit, flowers, sugar cane, nuts). From among 412 strains forming a cellulose membrane on the medium surface, one strain was selected, Acetobacter sp. BPR2001, characterised by particularly effective BC synthesis in mass culture. From 1500 monocultures originating from grapes, Kojima et al. isolated the Acetobacter strain S-35, characterised by highly elevated productivity in the presence of glucose, as well as fructose, synthesizing 3.3 g/l/day, in a stationary culture [15]. The search for the most effective carbon source took into account not only its cost, but also its metabolism, since some metabolites may cause inappropriate conditions for cellulose synthesis. Jonas and Farah [13] compared various mono-, di- and polysaccharides, alcohols, organic acids and other compounds as substrates for cellulose synthesis. The best results were obtained using media containing D-arabitol or D-mannitol, rather than glucose. In these trials, the amount of cellulose formed was about 6 and 4 times higher respectively, in comparison to a trial using glucose. It was shown that xylulose and fructose are the metabolites of these substrates, and thus the pH of the culture is maintained at the same level. The productivity obtained in these studies was nevertheless much lower than that obtained by Masaoka et al. [19], who using lower glucose concentrations obtained 0.6 g BC/g glucose/day following 2-4 of culture. Recently published results of research into the effects of various carbon and nitrogen sources on BC synthesis show that saccharose, glucose and mannitol with hydrolysed caseine , peptone, glutamate or ammonium sulphate as a nitrogen source were optimal for cellulose biosynthesis, Raman et al. [23]. In most of the published research, the efficiency of BC synthesis in a medium with glucose or fructose was lower than the efficiency of the above mentioned, and ranged from 0.02 g BC/g/day to 0.07 g BC/g/day [13]. Among other carbon compounds used in this process, citrate, gluconate and lactate should be mentioned. Geyer et al. [7] showed that citrate can me metabolised by Acetobacter, but only when the medium contained both citrate and glucose, where the latter will be utilised first, and the citrate after it has been depleted. It was also noted that citrate has a beneficial effect on the synthesis of cellulose. Other authors indicate gluconates as one of the possible carbon sources in cellulose [13]. Masaoka et al. [19] show that gluconates accumulated in the medium, up to a concentration of 20 g/1, were utilised by the bacteria. Matsuoka et al. [20] observed that lactate (0.15% v/v) added to a medium containing fructose, yeast extract and peptopne as a nitrogen source, exhibits a stimulating effect on the production of bacterial cellulose. In order to produce lactate into the culture medium, mixed cultures were maintained, containing bacteria producing acetic acid and lactic acid. The best results were obtained using strains of Lactobacillus, Leuconostoc and Pediococcus. These bacteria were also cultured in the presence of the yeast Sacharomyces in order to hydrolyse saccharose using β-fruktofiiranosidase. This method helps increase the efficiency of BC synthesis, because after 14 days of mass culture some 8,1 g cellulose were obtained from 1 litre of medium, as compared to thr 6,4 g/1 obtained without using Lactobacillus [31]. Ethanol may also be one of the stimulating factors of BC synthesis [21]. The results from a continuous culture of Acetobacter xylinum using a medium containing fructose and ethanol show that an ethanol concentration of 10 g/1 significantly increases BC synthesis efficiency, whereas at 15 g/1 it is inhibitory. Based on these results, it may be surmised that just as for lactate, the ethanol acts as a source of energy accumulated as ATP, and is not a substrate for cellulose synthesis. ATP activates fructokinase, and inhibits glucose-6-phosphate dehydrogenase, thereby inhibiting the conversion of 6-phosphoglucose to 6- phosphogluconates. It was also noted that the addition of ethanol to the culture medium helped prevent the spontaneous mutation of the Acetobacter sp. A9 strain into the Ceϊ form, which is incapable of synthesizing cellulose. The precise mechanism driving this phenomenon is not understood, however. Research into the effects of vitamins on BC synthesis has shown that the best stimulators are pirydoxin, nicotinic acid, p-aminobenzoic acid, and biotin [12, 20]. Fontana et al. [5] successfully used plant extracts, particularly from black tea, which contained components which stimulate cellulose synthesis. Mathematical methods are also used to optimise the culture medium, which has led to a large increase in the efficiency of cellulose synthesis [4, 6]. Analysis of the effect of pH on the synthesis of cellulose by Acetobacter xylinum has shown a pH optimum between 4.0 a d 7.0. depending on the specific requirements of the strain [13]. Masaoka et al. [19] determined that a pH between 4,0 - 6,0 is optimal for BC synthesis, where 80% of the product accumulates from pH 3,5 to 7,0. In a majority of the research cited, the optimal temperature for the biosynthesis of cellulose, the optimal temperature was found to be from 25-30°C, though a temperature of 28- 30°C was used most often [9, 13, 7, 11, 14]. Bacterial cellulose biosynthesis can be maintained both in stationary cultures and in liquid mass cultures. Generally, the selection of the method to be employed is dependent upon the planned use of the synthesized polymer [16]. The control over the process is greatly complicated in a stationary culture by a membrane which forms on the surface of the medium, which in turn limits access to the medium. BC synthesis in stationary conditions can occur using a single-step procedure (a medium inoculated with a 5-10% inoculate) or a two-step procedure [2]. The latter also includes a liquid culture stage in order to amplify the biomass, and then a continuation in a stationary culture [22]. Large scale cellulose production in constantly mixed cultures is complicated by a series of difficulties, the greatest of which is the culture's instability characterised by a tendency for the strains to spontaneously mutate into inactive forms, the so called Ceϊ [30]. An unstable strain can be successfully used in a stationary culture, in which bacterial growth and cellulose synthesis occurs at the air-medium phase border. Ceϊ cells are favoured in a shaken culture, in which the growth of Cet bacteria is limited by the rate of oxygen dissolution and cell aggregation by the synthesized cellulose (which limits oxygen access). Bacterial cellulose may also be produced in a continuous stationary culture [26]. Acetobacter xylinum cells are in this case cultured on trays, on SH medium. Following 2-3 days of synthesis, the cellulose membrane produced on the medium's surface is continuously fed into a bath in a solution of sodium dodecyl sulphate (SDS) in order to inactivate the cells, and is then rolled onto a special roller. This process was maintained for several weeks, at a rate of 35 mm/h, and periodic replenishment of the medium (every 8-12 hours), in order to maintain optimal culture conditions. In this way, a 5 m long cellulose belt was produced which indicates the possible utility of this method in industrial processes. Another described method of cellulose synthesis is an Acetobacter culture in horizontal bioreactors equipped with w rotating rollers, on which the produced polymer accumulated [27]. The observed bacterial growth was accelerated, and the efficiency of cellulose biosynthesis was almost doubled when compared to a stationary control culture. Bacterial cellulose has great utility in medicine, particularly as a wound dressing and for artificial organs. This is due to properties such as being highly crystalline, high mechanical strength, an ability to absorb fluids, and excellent histocompatibility with living tissue, particularly with blood, specially purified cellulose membranes produced in a stationary culture may be a ready wound dressing, which meets all standards for modern dressing materials [17, 5]. It is biocompatible, porous, elastic, easy to apply and easy to store. It maintains optimum moisture during the healing of a wound, and may be sterilised using high temperature. Cellulose membranes are also excellent media for the immobilisation of various bioactive substances, to accelerate healing processes. Remembering the latest problems and controversies surrounding products of animal origin, collagen bandages can be replaced with cellulose ones. To date, several reports have been made regarding positive results in clinical tests of bacterial cellulose as a burn trauma dressing, trophic rash dressing, or as a biomaterial for skin transplantation [3, 13, 24]. The properties of bacterial cellulose open up many possible and economically feasible practical applications, if improved culturing methods are taken into account with improved strains of Acetobacter, which utilise inexpensive and easily available materials.
Patent descriptions PL 171952 (published 1995.02.06) and application P-317139 (submitted 1996.11.20) relate to a method of producing bacterial cellulose membranes through a surface culture of Acetobacter xylinum, on a glucose-based medium. This solution is based on the isolated Acetobacter xylinum strain P23, of the genus Acetobacter, a typically aerobic species characterised in its ability to produce acids from an incomplete oxidation of carbohydrates and alcohols, which exists as oval rods, singly or doubly or arranged into chains, and has an optimal growth temperature of 28-30°C at a pH of 4 -6.5 on solid media containing glucose, yeast extract, peptone, and agar. In liquid media, it forms a dense mucuslike membrane. The acids it produces as temporary or terminal products are released into the culture environment. In the presented solution, the isolated Acetobacter xylinum P23 strain is incubated in a liquid medium. A method according to the present invention produces cellulose membranes containing 90 - 97% α-cellulose. Membranes produced by this method may be used as a dressing in surgery and dermatology. Patent description US5472859 (published in 1995.12.05) describes a method for the enzymatic production of new forms of cellulose and another for in vitro. In the first method, cellulose is synthesized in a reaction catalyzed by endoglucanase, in the presence of an active form of saccharide substrate in an organic solvent environment. The second method relates to the synthesis of cellulose in a reaction catalyzed by glycosyl transferase, in the presence of UDPG, in an aqueous environment in conditions conducive to polymerisation and crystallisation of parallel glucan chains from the enzyme/mycelle complex. Patent descriptions US5975095 (published in 1999.11.02), US5962278 (published in
1999.10.05), US6110712 (published in 2000.08.29) present a solution relating to the synthesis of cellulose by Acetobacter xylinum subsp. nonacetoxidans, which do not oxidize acetates and lactates, or oxidize them to an insignificant extent. Patent descriptions US6429002 (published in 2002.08.06), US6329192 (published in 2001.12.11), US5144021 (published in 1992.09.01), US5079162 (published in 1992.01.07),
US4863565 (published in 1989.09.05) present a solution relating to the production of bacterial cellulose in a shaken environment, in which over 70 h at least OJg/L was produced.
The cellulose produced was strongly crosslinked, and very resilient. Patent description US5955325 (published in 1999.09.21) presents a solution relating to microbiological cellulose with a high water content, produced in a disc fermenter. Patent description EP0792935 (published in 2003.03.05) presents a process of cellulose production in a fermenter, at a CO2 partial pressure of 10.13 kPa (0J0 atm) or less in the gaseous phase of the fermenting chamber. Patent description JP54041321 (published in 1979.04.02) presents a method for the production of a dressing for skin lesions, which has excellent local adherence and long-term activity, using hydroxypyrocellulose and polyacryllic acid salts and their active ingredient. Patent description EP0918548 (published in 1997.06.02) presents a solution relating to the application of oxidized cellulose, preferentially oxidized regenerated cellulose (ORC) and their complexes with proteins such as collagen, in order to provide a protective dressing for chronic wounds. Patent description WO8602095 (published 1986.04.10) relates to a method of producing a cellulose film as an artificial skin to be used in grafting. The method of producing the cellulose film encompasses the preparation of a culture medium, in which the nutrient media are nitrates and carbohydrates, which is inoculated with Acetobacter xylinum. It also encompasses incubation at a temperature ensuring bacterial activity during the time the film is being produced, and removal of the film for dehydratation under tension. Patent descriptions US4788146 (published 1988.11.29), and US4588400 (published 1986.05.13) relate to the application of cellulose membranes as dressings for wounds and abrasions, as well as thermal wounds. They are produced in a culture of Acetobacter xylinum, to a thickness of 0J do 15 mm or more and are sterilised following removal, while they are still highly hydratated. Despite the above mentioned studies on the production of bacterial cellulose, and the application bacterial cellulose as wound dressing material, a real need still exists to: obtain effective tools for the synthesis of bacterial cellulose, to select highly active, stable bacterial strains, to optimise the culture medium including its economic aspects to perfect the technologies, and to perfect the resulting material, which will broaden its possible applications.
The goal of the present invention is to provide the means which could be used to synthesise bacterial cellulose, and to obtain it for the production of wound dressings possessing certain, defined qualities determined by their intended usage. Unexpectedly, the embodiment of the above stated goal and a solution to the problems described in the state of the art regarding: the production of bacterial cellulose in membrane form, the application of bacterial cellulose for the production of biocatalysts, the production of formulations which allow bacterial cellulose to be used as a wound dressing for extensive burns; have been achieved by the present invention.
The subject of the present invention is a method for the production of bacterial cellulose, characterised in that a culture of Acetobacter xylinum is maintained on an appropriate medium for the production of a cellulose surface membrane, which is then separated from the culture liquid, and further purified. Preferentially, this process encompasses after the further purification the sterilisation process. Preferentially, this process encompasses the initial culture phase, as well as the proper production phase.
Preferentially, this process encompasses the initial culture phase, in which the culture medium is inoculated with Acetobacter xylinum bacteria and they are cultured to achieve a density of ca. 5x107 cfu/ml, and then this inoculum is used to inoculate the production culture.
Preferentially, the culture medium is characterised by the following composition by weight: 10 - 30 parts glucose, 2.5 - 12.5 parts yeast extract, 2.5 - 12.5 parts peptone, 1.25 - 6.25 parts MgSO4 x 7H2O, 1.25 - 7 parts Na2HPO4, 0.5 - 3 parts citric acid, 5 - 100 parts ethanol to 1000 parts distilled water. Preferentially, the culture medium used in the initial culture is inoculated with 5 - 10%o (v/v) of the inoculum. Preferentially, the method of preparing the inoculum consists of inoculating culture medium with a bacterial culture at an amount of 5 - 10%, maintained in this medium at maximum 48 h, at a temperature of 27-33°C.
Preferentially, following intensively mixing the culture with the formed membrane, the bacterial suspension is used to inoculate the production medium.
Preferentially, prior to the proper production culture, the inoculated medium is preincubated in the bioreactor.
Preferentially, the preincubation of the inoculated medium is performed with constant shaking. Preferentially, the inoculated medium is preincubated up to 24 h at a temperature of 27 -33°C.
Preferentially, the inoculated medium is thoroughly mixed and poured into the bioreactor, and cultured for 5-10 days.
Preferentially, the proper production culture is maintained without shaking.
Preferentially, the membranes produced are removed and thoroughly purified. Preferentially, the membranes produced are thoroughly cleaned, by rinsing in water, by boiling in a 1 - 3% NaOH solution for 0.5 - 2 hours, rinsing again to remove all traces of
NaOH, treating with 0.5 - 3% acetic acid, rinsing with tap water and then distilled water.
Preferentially, the membranes produced are rolled, pressed, and wringed, to remove excess water, packed into sealed foil and sterilized by irradiation, using doses of 20 - 25 kGy. Preferentially, the carbon source in the production medium for the synthesis of bacterial cellulose is a byproduct of industrial production of glucose.
Preferentially, the composition of the production medium for the synthesis of bacterial cellulose is based on byproduct constituents of plant origin.
Preferentially, the process encompasses preparing the production medium for the synthesis of bacterial cellulose, in which the carbon source is byproduct material containing 45 - 70% glucose, 10 - 15% isomaltose, 5 - 6 gentiobiose or glucose-fructose syrup (1:1) or molasses containing 40 - 60% saccharose and glucose from 5 - 25% or the effluent from the dextran microbiological synthesis.
Preferentially, the effluent from the microbiological synthesis of dextran contains 10 - 15% fructose, 0.05 - 2% glucose and 1 - 6%> saccharose or glycerol.
Preferentially, the nitrogen source in the culture medium is corn steep liquor.
Preferentially, in the culture medium 3 - 5 parts yeast extract and 3 - 5 parts peptone from the culture medium are replaced with 15 - 25 parts of corn steep liquor.
Preferentially, the liquid following the end of culturing is reused to produce the medium. Preferentially, the culture medium is supplemented with 3 - 8 parts carboxymethylocellulose
(CMC) with a molecular mass between 90.000 - 250.000.
Preferentially, the 3 - 5 parts yeast extract and 3 - 5 parts peptone from the culture medium are replaced by introducing the inoculate liquid as a nitrogen source. Preferentially, the cellulose biosynthesis in the stationary culture is maintained in such conditions, that the S/N ratio (bioreactor surface/volume) is 0.5-0.9 cm"1.
Preferentially, the stability and synthesis of cellulose in a stationary culture is warranted by
0.5 - 3% ethanol present in the medium. The subject of the present invention is a method of immobilising Bacillus subtilis bacteria, characterised in that the immobilisation carrier is a mixture of polyvinyl alcohol (PNA) with a mass of 72000, at a concentration of 10 - 12% and pulverised bacterial cellulose at 0J2 -
12%.
Preferentially, the mixture is cryo-gelled into spherical forms through repetitive freezing at temperatures between— 17 and -25°C and defrosting at ca. 20°C, in vegetable oil.
The subject of the present invention is a method of producing immobilised biocatalysts, characterised in that the bacterial cellulose synthesized by the isolated strain of Acetobacter xylinum, P3o, belonging to the genus Acetobacter, in a stationary culture, is used to produce a carrier to immobilise the yeast Saccharomyces cerevisiae and the bacteria Bacillus subtilis. Preferentially, the bacterial cellulose is synthesized in a liquid medium containing 10 - 30 parts glucose, 10 - 30 parts com steep liquor, 5 - 15 parts ethanol, at a temperature of 27 -
33°C over 5 - 10 days, and subsequently cleaned with 1 - 3% ΝaOH at a temperature of 80-
100°C, for 30-120 min and rinsed with water.
The subject of the present invention is an application of bacterial cellulose produced in a stationary culture of an Acetobacter xylinum strain as a wound dressing, particularly for bums and surgical wounds.
Preferentially, the bacterial cellulose is used in the form of cellulose membranes of arbitrary shape and size.
Preferentially, dressings made of bacterial cellulose secure the surface of wounds against excessive extranefrous water loss.
Preferentially, bacterial cellulose dressings ensure a moist environment and seal the surface of the wound.
Preferentially, the modified cellulose material is used.
The subject of the present invention is a method of modifying cellulose membranes, characterised in that it consists of selective oxidation of bacterial cellulose using oxidative agents.
Preferentially, the cellulose membranes are produced in the presence of CMC.
The subject of the present invention is a method of modifying cellulose membranes, characterised in that it consists of the saturating the membrane with a solution of 1-6 % glycerol, 0.5 - 4 % PEG 400, 0.01 - 1 % chlorohexidine.
The subject of the present invention is a method of modifying cellulose membranes, characterised in that it consists of the production of composites consisting of cellulose and monomers and/or polymers and/or nanofibres and/or textiles during culturing. Preferentially, the composite is the additional binding agent for bioactive substances promoting healing.
Preferentially, the composite increases the pressure applied to the wound.
Preferentially, the composite elongates the drying-out time of the dressing.
The attached figures facilitate a more thorough explanation of the nature of the present invention.
Figure 1 shows a deep 2b bum of moderately thick skin of the forearm, hand and fingers of the right hand with the cellulose dressing. Figure 2 shows the application of a cellulose dressing. The dressing covers all of the back of the neck, back and loin area.
Below are listed example embodiments of the present invention defined above.
Production of cellulose membranes using modified culture media (examples 1-9) Example 1.
The PI inoculation medium containing the following constituents by mass: 20 parts glucose, 5 parts yeast extract, 5 parts peptone, 2.5 parts MgSO4x7H O, 2.7 parts Na2HPO , 1J5 parts citric acid, 10 parts of ethanol, to 1000 parts distilled water; is inoculated with 5% (v/v) of a suspension of Acetobacter bacteria (5x107 units/ml) maintained in that medium no longer than 7 days, at a temperature of 4°C. It is incubated for 2 days at a temperature of 30°C, when, following intensive mixing, the suspension is used to inoculate production medium of the same composition at a rate of 5% of production medium volume. The whole volume is then preincubated for 24 h at a temperature of 30°C, and it is then transferred into bioreactors of an appropriate volume, such that the S/N ratio (surface/volume) is 0.7 cm"1. Using a bioreactor with a surface area of 10 000 cm2, 14 dm3 of culture medium is prepared, which following inoculation and preincubation is used to maintain the production culture proper in the bioreactor in stationary conditions over 7 days, whence the 5mm thick membranes formed are cleaned with tap water. They are then treated with 1% ΝaOH at a temperature of 100°C, for 1 hour, again rinsed in tap water, and then treated with l%acetic acid, once again in tap water, and finally in distilled water. Excess water is removed through wringing, and then the membranes, with ca. 90% of their water removed, are placed in sealed foil bags and sterilised by irradiation using a dose of γ rays at 25 kGy. Using the PI medium it is possible to obtain ca. 3.5 g cellulose dry mass from 1 dm of medium, and its protein content will not exceed 3%. Example 2
An inoculate obtained as per Example 1 was used to inoculate sterile production medium composed of the following by mass: effluent from glucose crystallisation in an amount corresponding to 2% glucose, 20 parts maize mash and 10 parts ethanol in 1000 parts distilled water. Then, the procedure was as per Example 1 and as a result a mass of cellulose comparable to Example 1 was obtained.
Example 3 An inoculate obtained as per Example 1 was used to inoculate sterile production medium containing as a carbon source glucose-fructose syrup (1:1) in an amount corresponding to 1% glucose and 1% fructose and the remaining components like in medium PI. Then, the procedure was as per Example 1 and as a result a mass of cellulose ca. 15% higher than in Example 1 was obtained.
Example 4
An inoculate obtained as per Example 1 was used to inoculate sterile production medium, in which the fructose source utilised was 50 parts by mass of fructose effluent, a byproduct of separation of dextrans from a Leuconostoc mesenteroides culture and 2 parts ethanol and 5 parts of yeast extract, and distilled water to 1000 parts. Then, the procedure was as per Example 1 and as a result a mass of cellulose ca. 20% higher than in Example 1 was obtained.
Example 5
An inoculate obtained as per Example 1 was used to inoculate sterile production medium, in which the carbon source was molasses in an amount such that the saccharose contained therein amounted to 50 parts by mass, and 5 parts yeast extract as the nitrogen source, 10 parts ethanol, and distilled water to 1000 parts. As a result a mass of cellulose ca. 75% of the mass of cellulose from Example 1 was obtained.
Example 6
An inoculate obtained as per Example 1 was used to inoculate sterile PI production medium, in which 5 parts of yeast extract and 5 parts peptone were replaced with 20 parts maize mash, not altering the remainder of the components. Then, the procedure was as per Example 1 and as a result a mass of cellulose ca. 10% higher than in Example 1 was obtained. Example 7
An inoculate obtained as per Example 1 was used to inoculate sterile PI production medium, in which 50% was liquid from a 7 day culture. Then, the procedure was as per Example 1 and the results were comparable to Example 1.
Example 8
An inoculate obtained as per Example 1 (10% v/v) was used to inoculate sterile PI production medium, which was missing yeast extract and peptone, leaving the other components unchanged. The nitrogen source in this case was contained in the inoculate sample, 100 parts by weight. Then, the procedure was as per Example 1 and as a result a mass of cellulose ca. 70% of the mass from Example 1. The membrane produced in these conditions was white and more clear, which made the purification process much less labour intensive.
Example 9 The effect of CMC on the mass of produced cellulose membranes
The bacteria were cultured for 7 days on a modified SH medium, containing an addition of 1% ethanol and 0.05% MgSO x7H2O, at a temperature of 30°C, in 500 ml Erlenmeyer flasks containing 100 ml of medium enriched with 1.0% CMC1 (90.000) or CMC2 (250.000). After purification according to the method presented in Example 1, the membranes produced during this period were air-dried to a solid, dry mass, which varied between 0.55 g depending on the degree of CMC polymerisation. In the presence of CMC 1, at an increasing concentration in the range 1%, the masses of the membranes produced were, respectively, 0.55 g, whereas they were 0.31 g without CMC or 0.50 g with CMC2.
Application of bacterial cellulose for the production of immobilised biocatalysts (examples 10-12) Example 10 0.12% of bacterial cellulose powder is added to a 10% polyvinyl alcohol solution
(molecular mass 72 kDa and polymerisation degree 1600) along with a suspension of Bacillus subtilis at 7,6 x 109/ml. The mixture obtained is cryo-gelled into spherical shapes using 5 stages of freezing at -20°C and defrosting at 20°C, in vegetable oil. In parallel a control is run without bacterial cellulose. To test the mechanical resistance of such biopreparations they were suspended in water and shaken at 150 rpm, at a temperature of 55°C, while measuring their dissolution times. The dissolution time of the sample with bacterial cellulose lengthened to 45 min, whereas for samples without cellulose, the time was 10 min. In order to determine the proportion of bacteria released from the carrier, biopreparation samples obtained as per Example 10 undergo triple rinsing in 30 min, using 1 ml aliquots of physiological saline. The suspension of released bacteria is swabbed onto medium solidified with agar, and counted after 24 h of culture at 37°C. After the third cycle of rinsing, 10 times less bacteria were released than from the sample without cellulose. Immobilised biopreparations produced as per Example 10 are used in the biosynthesis of proteolytic enzymes, introducing 4% of biocatalyst into 50 cm3 of sterile culture medium and incubating it at 30°C, for 66 h, constantly mixed at 220 rpm. The culture cycle was repeated 3 times using the same biopreparations, following washing with physiological saline. In each case the serine protease activity was 17% higher when the preparation contained bacterial cellulose.
Example 11 The cellulose membrane obtained as in Example 6 is ground down to a particle size of 2-3 mm, which are sterilised (120°C, 20 min.) and introduced at a rate of 1 g s. s. into a 4 hour shaken culture of the yeast, S. cerevisiae in 100 ml of medium containing: 10 parts saccharose, 5 parts of yeast extract, 0.5 parts (NH4)SO4, 0.7 parts MgSO4x7H2O, 0.5 parts KH2PO , 0.5 parts NaCl, distilled water to 1000 parts (pH=4,8). The culture is continued for the next 4 hours, after which the suspension of cellulose along with adsorbed yeast cells is separated from the medium, and following thorough a wash, used in the process of saccharose hydrolysis, using a 5% saccharose solution and the biopreparation at a ratio of 1 :5 by weight. One cycle lasted 10 hours, and there were 10 cycles. The highest degree of saccharose inversion, 97%, was achieved during the third cycle.
Example 12 The cellulose membrane obtained as in Example 6 was initially ground, and then particles 2-3 mm in diameter were homogenized at 13000 φm. The pulp obtained was centrifuged at 5000 φm. and the wet mass was added at a rate of 10% to a 2% sodium alginate solution, lg of wet yeast pulp was introduced into 20 cm3 of this mixture, thoroughly mixed, and dripped into an ice-bath chilled 2%> CaCl2 solution, with constant mixing. The spherical portions of the biopreparation were kept in the 2% CaCl2 solution at a temperature of 4°C for 12 hours. The produced biopreparation was used for continuous saccharose hydrolysis, using a 50% solution thereof. The process took place in a vertical reactor at a temperature of 40°C, with a 0.04 cm3/min substrate flow-through rate. After 30 days, the saccharose inversion was 80% when the carrier contained cellulose and 65% when it did not. This biopreparation was also used in the hydrolysis of 50% saccharose, using a periodic method of 6 cycles of 8 hours, and the preparation at 1 g per 18 g substrate. In every cycle, the degree of saccharose inversion was 25-30% higher using the biopreparation with the cellulose carrier, than when a non-cellulose carrier was used.. Application of cellulose membranes as filters (examples 13-14) Example 13 A cellulose membrane prepared as per Example 6, after 90% of the water was removed, was used in the form of a circle 10 cm in diameter to filter samples of apple juice, using a vacuum filter apparatus. In the comparative method of traditional filtration, 100 cm3 of juice was supplemented by 0.5 ml of 1% gelatine solution, and 0.5 ml 3% solution of siliconic acid, and then filtered through a filter containing Hyflo Super Cel diatomaceous earth. The filtered juices were subjected to stability testing by heating to a temperature of 80°C, chilling, and f eezing to -18°C for one hour, and then defrosted at room temperature. The comparative analysis is presented in Table 1.
Table 1
Figure imgf000015_0001
As the results indicate, the juice clarified via the cellulose membranes was characterised by a higher clarity before and after the stability test, when compared to the control. Following the stability assay, the juice samples filtered through the membranes exhibit a higher colour intensity.
Example 14 Using a culture medium like in Example 6, Acetobacter xylinum were cultured in a bioreactor 100x15x8,5 cm, which dimensions corresponded to the UF filtration module from Amicon for an RA 2000 device. The purified membrane, following removal of 90% of its water, was used as a filtration module to filter wine which exhibited a secondary, opalescent haze. The obtained samples of wine retained full clarity during the 6-month study period, maintained at room temperature. Example 15
Water-retention ability of membranes synthesized in the presence CMC and centrifuged
Membranes produced as per Example 9, following purification, were centrifuged at 176g for 15 min. It was determined that membranes spun at 176g, and produced in the presence of CMC1 at concentrations of 0.5% and 1% retain ca. 30% water, and with CMC2 at the same concentration, ca. 40%> water, whereas without CMC only 15% water.
Example 16 Water retention ability during drying at 37°C of membranes modified with CMC
Cellulose membranes produced according to Example 9 in the presence of 0.5% CMC with a m.m. of 90000 were purified, and dried at a temperature of 37°C. Following 3 hours of drying, the membrane produced in the presence of CMC lost ca. 17% of its water, whereas without CMC it lost 23%, and following 22 hours this was respectively 92,5% and 99%.
Example 17
Modification of cellulose membranes using sodium periodate (NaIO ) and their hydroscopic properties Cellulose membranes produced as per Example 1, were immersed in a sodium periodate solution, most preferentially 1%>, at a temperature of 22°C for 2 hours, and were then washed with distilled water to remove all traces of the periodate. The product obtained contained 2,75 mmol of aldehyde groups / g of dry mass and was 2 times more hydroscopic than unmodified membranes.
Example 18
Application of membranes oxidized with NaIO to immobilize lysozyme.
Membranes oxidized under conditions described in Example 17 were immersed in a 0.02% lysozyme solution, with an activity of 16800 U/mg, for 4 hours, at room temperature, and shaken at 100 φm. They were then washed with distilled water to rinse away any unbound protein. Compared with unmodified cellulose, oxidized cellulose binds about 2 times as much protein, meaning ca. 60%>.
Example 19
The cellulose membrane according to Example 1, was purified and excess water was removed (to 50% of initiall mass). It was then soaked in a solution containing 0,1% chlorohexidine, 6% glycerol, 4% PEG 400. The resulting material retained its elasticity following drying at room temperature, did not cling to skin, was easy to remove without need of prior moistening, and moreover exhibited bacteriocidal properties. Example 20
A membrane produced as in Example 1, following 4 days of culture, was used as a matrix for the application of sterile material (i.e. cotton cloth) with dimensions 2 cm less than the dimensions of the membrane, and the culture was maintained a further 4 days. During this time, a membrane is formed over the cloth, and it becomes sealed between the two membrane layers which fuse at the edges around the cloth. The membrane formed over the cloth is tightly bound to it, whereas a pocket is formed between the cloth and the matrix, which was filled with water or physiological saline in order to increase the mass of the material, and thus its exerted pressure, as well as to elongate its drying time. This pocket may also be filled with bioactive substances which may penetrate the wound and accelerate healing.
Example 21
Application of cellulose dressings to treat surgical incisions and burns in animals 40 female Wistar rats were used as experimental animals, aged 8-10 weeks with body masses ranging from 152 to 190g ( average 178g). The animals were divided into 4 groups of 10: Group A - rats with a surgical incision treated without dressing Group B - rats with a surgical incision treated with a cellulose dressing Group C - rats treated with a burn treated without dressing
Group D - rats treated with a bum treated with a cellulose dressing
The wound surface was an area of 2x3cm. Such a wound surface comprises from 1,9% to 2,5% (on average 2%) of body surface. In the case of bums, such a wound is considered light. The wounds were located on the dorsal side of the animal, below the shoulder blades. In the groups treated with a cellulose dressing, sterile cellulose patches were used according to Example 1. One hour prior to the treatment, the animals were pre-medicated and then following depilation a surgical wound was produced by removing a patch of skin with a scalpel, to its complete depth, or by producing a bum wound through the application of a steel plate 19x28xlmm heated to 500°C. This method rendered a III degree bum with a surface of 2x3 cm. The wound penetrated the entire thickness of the skin. The wound in group A was left to heal without a dressing. In group B, cellulose dressings were used, exchanged every alternate day. The burns in group C were treated without dressings. In group D, dressings were used as in group B. In order to prevent the animals from affecting the dressings, a plaster cast was put on their torso. After treatment, the animals were kept in individual cages. They received an analgesic in their water and standard feed.
To quantify the results, macroscopic examination criteria were used. The macroscopic and microscopic examinations of wound healing were performed after 7 and 21 days on 5 animals from each group. The animals were euthanised with an overdose of ether through inhalation. Material for microscopic observation was collected through the excision of skin, along with the area of healing or healed wounds. The material was fixed in 10% formaldehyde. Postfixation, paraffin sections were made which were stained with haematoxilin and eosin and examined microscopically. All rats survived the observation period. The results showed that for surgical wounds, the application of a cellulose dressing accelerated the healing and reconstruction of the epithelium, caused a lesser degree of inflammatory fluid seepage, and encouraged the preliminary formation of skin features. In the case of bums, application of the cellulose dressing caused: faster scab formation, more advanced epithelium formation, and preliminary formation of skin features.
Example 22 Clinical studies
Application of a bacterial cellulose dressing in the treatment of burns
Experimental group „A" encompassed 41 patients hospitalised at the Centre for Bum Treatment in Siemianowice Sla^skie, from the first day following IIA, IIB and/or III degree skin burns to 9-18% of the entire body surface area, of both sexes, aged 18-70 years old. These patients were diagnosed free of colagenosis, diabetes, uraemia, malignant tumours and were never treated with cytostatic drugs, radiation, immunosuppression and had not received blood or blood product transfusions. The local treatment of the bum consisted of applying dressings of bacterial cellulose in 10-day cyclesafter cleaning and disinfecting the burned surface. The cellulose membranes were produced according to Example 1 and sterilised through irradiation. The doctor-in-charge tightly covered the wound surface in sterile conditions [Fig. 1, 2] and additionally secured it with a 3% Braunol dressing. Control group „B" was composed of 12 patients selected according to the same criteria as above, locally treated according to standard methods, using dressings of 3% Braunol, 3% boric acid solutions, and salicylate paste in 10 day cycles. Following cleaning and local preparation of the wound, both groups were treated with (depending on medical indication) a skin graft of moderate thickness. For all patients in groups A and B, the Parcland crystalloid rule was applied during the first day of hospitalisation, and as of the second day, systemic water loss was measured using the haematocrit.
Before the wound was cleaned on the 5th and 10th days of treatment, smears for microbiological analysis were taken, and urine samples were taken on the 1st day. All patients were treated with targeted antibiotics starting on the 5th day of hospitalisation (as indicated medically). In both groups blood moφhology and the haematocrit were measured, as were the sodium and potassium levels were in peripheral blood, total blood protein, and albumin levels on the 1st, 5th and 10th days of treatment. Photographs of the wounds were taken on the same day. On the 10 day, excisions were made in both groups for histo-pathological analysis. All cellulose dressings from group A were evaluated on day 1 and day 10 of the treatment. The 10 day treatment observation cycle allowed to repeat until such time as the wound was fit for an autogenic skin transplant of moderate thickness. Graft healing was evaluated and documented photographically during the 2nd, 7th and 12th day following the operation. The number of 10 day intervals of preparatory treatment were determined, as was the total time of healing for the wound covered with the graft.
The research showed that: Wounds treated with a cellulose dressing are well insulated from the environment. The dressing protects the wound from infection and tissue fluid loss. The dressings reduce the subjective sensation of pain in the bum patients. - The dressings are well tolerated by the patients, and must be kept on the wounds until the completion of epithelium formation. The dressings maintain a moist environment and create opportunities for further moistening. - In shallow bums, the dressings accelerate epithelium formation, and in deep bums they accelerate necrosis demarcation. The possibility to produce a cellulose dressing of arbitrary chape and size enables the whole wound to be covered with one dressing. The speed at which the dressing is applied to the wound post-trauma, while maintaining asepsis is conditional the effectiveness of the treatment (without scarring). Literature
1. Ben-Bassat A., Calhoon R. D., Fear A. L., Gelfand D. H., Mead J. H., Tal R., Wong H., Benziman M. (1993) Methods and nucleic acid sequences for expression of the cellulose synthase operon. US Patent 5,268,274.
2. Bielecki S., Krystynowicz A., Turkiewicz M., Kalinowska H. (2001) Bacterial cellulose. In: Biopolymers Vol. 7: Polysaccharides and (Steinbuchel, Ed.) Munster, Germany, 37-90.
3. Bungay H., Serafica G. (1997) Production of microbial cellulose using a rotating disc film bioreactor. Patent WO 97/05271.
4. Embuscado M. E., Marks J. S., Miller J. N. (1994) Bacterial cellulose. II. Optimization of cellulose production by Acetobacter xylinum thru response surface methodology. Food Hydrocolloids 8, 419-430.
5. Fontana J. D., Franco V. C, de Sousa S. J., Lyra I. N., de Sousa A. M. (1991) Nature of plant stimulators in the production of Acetobacter xylinum ("tea fungus") biofilm used in skin therapy. Appl. Biochem. Biotechnol. 28/29, 341-351.
6. Geyer U., Klemm D., Schmauder H. P. (1994) Kinetics of the utilization of different C sources and the cellulose formation by Acetobacter xylinum. Acta Biotechnol. 14, 261- 266. 7. Haigler C. H. (1985) The function and biogenesis of native cellulose, in: Cellulose Chemistry and its Applications (Nevel R. P., Zeronian S. H., Eds.), 30-83. Chichester, England: Ellis Horwood.
8. Hestrin, S. and Schramm, M. (1954) Synthesis of cellulose by Acetobacter xylinum. II. Preparation of freeze-dried cells capable of polymerizing glucose to cellulose, Biochem. J. 58, 345-352.
9. Hirai A., Horii F. (1999) Cellulose assemblies produced by Acetobacter xylinum. ICR Annual Report 6, 28-29.
10. Iguchi M., Yamanaka S., Budhiono A. (2000) Bacterial cellulose - a masteφiece of nature's arts. J. Mat. Sci. 35, 261-270. 11. Ishikawa A., Masuoka M., Tsuchida T., Yoshinaga F. (1995) Increasing of bacterial cellulose production by sulfoguanidine-resistant mutants derived from Acetobacter xylinum subsp. sucrofermentans BPR2001. Biosci. Biotech. Biochem. 59, 2259-2263. 12. Jonas R., Farah L. F. (1998) Production and application of microbial cellulose. Polymer Degrad. Stabil. 59, 101-106. 13. Kamide K., Matsuda Y., Iijima H., Okajima K. (1990) Effect of culture conditions of acetic acid bacteria on cellulose biosynthesis. British Polymer Journal 22, 167-171. 14. Kojima Y., Seto A., Tonouchi N., Tsuchida T., Yoshinaga F. (1997) High rate production is static culture of bacterial cellulose from sucrose by a newly isolated Acetobacter strain. Biosci. Biotech. Biochem. 61(9), 1585-1586.
15. Krystynowicz A., Czaja W., Bielecki S. (1999) Biosynteza and mozliwosci wykorzystania celulozy bakteryjnej. Zywnosc 3(20), 22-34.
16. Krystynowicz A., Czaja W., Pomorski L., Kolodziejczyk M. and Bielecki S. (2000) The evaluation of usefulness of microbial cellulose as wound dressing material. 14th Forum for Applied Biotechnology, Gent, Belgium, Meded Fac. Landbouwet Rijksuniv. Gent, Proceedings Part I, 213-220. 17. Kudlicka K. (1989) Terminable kompleksy syntazy celulozowej. Postepy biologii komόrU 16(2), 197-212.
18. Masaoka S., Ohe T., Sakota N. (1993) Production of cellulose from glucose by Acetobacter xylinum. J. Ferment. Bioeng. 75, 18-22.
19. Matsuoka M., Tsuchida T., Matsuchita K., Adachi O., Yoshinaga F. (1996) A synthetic medium for bacterial cellulose production by Acetobacter xylinum subsp. sucrofermentans. Biosci. Biotech. Biochem. 60 (4), 575-579.
20. Naritomi T., Kouda T., Yano H., Yoshinaga F. (1998) Effect of ethanol on bacterial cellulose production from fructose in continuous culture. J. Ferment. Bioeng. 85(6), 598-603. 21. Okiyama A., Motoki M., Yamanaka S. (1992) Bacterial cellulose II. Processing of the gelatinous cellulose for food materials. Food Hydrocolloids 6, 479-487. 22. Ramana K. V., Tomar A., Singh L. (2000) Effect of various carbon and nitrogen sources on cellulose synthesis by Acetobacter xylinum. World Journal of Microbiology & Biotechnology 16, 245-248. 23. Ring D. F., Nashed W., Dow T. (1986) Liquid loaded pad for medical applications. US Patent 4588400. 24. Ross P., Weinhouse H., Aloni Y., Michaeli D., Ohana P., Mayer R., Braun S., de Nroom E., van der Marel G. A., van Boom J. H., Benziman M. (1987) Regulation of cellulose synthesis in Acetobacter xylinum by cyclic diguanylic acid. Nature 325, 279-281. 25. Sakairi Ν., Asano H., Ogawa M., Νishi Ν., Tokura S. (1998) A method for direct harvest of bacterial cellulose filaments during continuous cultivation of Acetobacter xylinum. Carbohydr. Polymers 35, 233-237. 26. Sattler K., Fiedler S. (1990) Production and application of bacterial cellulose. Zentralbl. Microbial. 145, 247-252. 27. Saxena I. M., Lin F. C, Brown Jr R. M. (1990) Cloning and sequencing of the cellulose synthase catalytic subunit gene of Acetobacter xylinum. Plant Molecular Biology 15, 673-683. 28. Saxena I. M., Lin F. C, Brown Jr R. M. (1991) Identification of a new gene in an operon for cellulose biosynthesis in Acetobacter xylinum. Plant Molecular Biology 16, 947-954.
29. Schramm M. and Hestrin S. (1954) Factors affecting production of cellulose at the air/liquid interface of a culture of Acetobacter xylinum. J. Gen. Microbiol. 11, 123.
30. Seto H., Tsuchida T., Yoshinaga F. (1997) Manufacture of bacterial cellulose by mixed culture of microorganisms. PNJP 97-21905.
31. Toyosaki H., Naritomi T., Seto A., Matsuoka M., Tsuchida T., Yoshinaga F. (1995) Screening of bacterial cellulose-producing Acetobacter strains suitable for agitated culture. Biosci. Biotech. Biochem. 59(8), 1498-1502.
32. NanderHart D. L., Atalla R. H. (1984) Studies of microstructure in native celluloses using solid-state 13C ΝMR. Macromolecules 17, 1465-1472.
33. Wong H. C, Fear A. L., Calhoon R. D., Eichinger G. H., Mayer R., Amikam D., Benziman M., Gelfand D. H., Meade J. H., Emerick A. W., Bruner R., Ben-Bassat A., Tal R. (1990) Genetic organization of the cellulose synthase operon in Acetobacter xylinum. Proc. Natl. Acad. Sci. USA 87, 8130-8134.

Claims

Patent Claims
A method of producing bacterial cellulose, characterised in that Acetobacter xylinum bacteria are cultured in an appropriate medium for the production of a surface cellulose membrane, which is then isolated from the culture liquid and further purified.
2. A method according to Claim 1, characterised in that the process encompasses after the further purification the sterilisation process.
3. A method according to Claim 1, characterised in that the process encompasses the initial culture phase, as well as the proper production phase.
4. A method according to Claim 1, characterised in that the process encompasses the initial culture phase, in which the culture medium is inoculated with Acetobacter xylinum bacteria and they are cultured to achieve a density of ca. 5x107 cfu/ml, and then this inoculum is used to inoculate the production culture.
5. A method according to Claim 1, characterised in that the culture medium is characterised by composition by weight: 10 - 30 parts glucose, 2.5 - 12.5 parts yeast extract, 2.5 - 12.5 parts peptonu, 1.25 - 6.25 parts MgSO4 x 7H2O, 1.25 - 7 parts Na2HPO4, 0.5 - 3 parts citric acid, 5 - 100 parts ethanol to 1000 parts distilled water.
6. A method according to Claim 1, characterised in that the culture medium used in the initial culture is inoculated with 5-10% (v/v) of the inoculum.
7. A method according to Claim 1, characterised in that the method of preparing the inoculum consists of inoculating culture medium with a bacterial culture at an amount of 5 - 10%, maintained in this medium at maximum 48 h, at a temperature of 27-33°C.
8. A method according to Claim 1, characterised in that following intensively mixing the culture with the formed membrane, the bacterial suspension is used to inoculate the production medium.
9. A method according to Claim 1 , characterised in that prior to the proper production culture, the inoculated medium is preincubated in the bioreactor.
10. A method according to Claim 1, characterised in that the preincubation of the inoculated medium is performed with constant shaking.
11. A method according to Claim 1, characterised in that the inoculated medium is preincubated up to 24 h at a temperature of 27-33°C.
12. A method according to Claim 1, characterised in that the inoculated medium is thoroughly mixed and poured into the bioreactor, and cultured for 5-10 days.
13. A method according to Claim 1, characterised in that the proper production culture is maintained without shaking.
14. A method according to Claim 1, characterised in that the membranes produced are removed and thoroughly purified.
15. A method according to Claim 1, characterised in that the membranes produced are thoroughly cleaned, by rinsing in water, by boiling in a 1 - 3% NaOH solution for 0.5 - 2 hours, rinsing again to remove all traces of NaOH, treating with 0.5 - 3% acetic acid, rinsing with tap water and then distilled water.
16. A method according to Claim 1, characterised in that the membranes produced are rolled, pressed, and wringed, to remove excess water, packed into sealed foil and sterilized by irradiation, using doses of 20 - 25 kGy.
17. A method according to Claim 1, characterised in that the carbon source in the production medium for the synthesis of bacterial cellulose is a byproduct of industrial production of glucose.
18. A method according to Claim 1, characterised in that the composition of the production medium for the synthesis of bacterial cellulose is based on byproduct constituents of plant origin.
19. A method according to Claim 1, characterised in that it encompasses preparing the production medium for the synthesis of bacterial cellulose, in which the carbon source is a byproduct material containing 45 - 70% glucose, 10 - 15% isomaltose, 5 - 6 gentiobiose or glucose-fructose syrup (1:1) or molasses containing 40 - 60% saccharose and glucose from 5 - 25% or the effluent from the dextran microbiological synthesis.
20. A method according to Claim 1, characterised in that the effluent from the microbiological synthesis of dextran contains 10 - 15% fructose, 0.05 - 2% glucose and 1 - 6% saccharose, or glycerol.
21. A method according to Claim 1, characterised in that nitrogen source in the culture medium is com steep liquer.
22. A method according to Claim 1, characterised in that the 3 - 5 parts yeast extract and 3 - 5 parts peptone from the culture medium are replaced with 15 - 25 parts of com steep liquor.
23. A method according to Claim 1, characterised in that the liquid following the end of culturing is reused to produce the medium.
24. A method according to Claim 1, characterised in that the culture medium is supplemented with 3 - 8 parts carboxymethylocellulose (CMC) with a molecular mass between 90.000 - 250.000.
25. A method according to Claim 1, characterised in that the 3 - 5 parts yeast extract and 3 - 5 parts peptone from the culture medium are replaced by introducing the inoculate liquid as a nitrogen source.
26. A method according to Claim 1, characterised in that the cellulose biosynthesis in the stationary culture is maintained in such conditions, that the S/N ratio (bioreactor surface/volume) is 0.5-0.9 cm"1.
27. A method according to Claim 1, characterised in that the stability and synthesis of cellulose in a stationary culture is warranted by 0.5 - 3% ethanol present in the medium.
28. A method of immobilising Bacillus subtilis bacteria, characterised in that the immobilisation carrier is a mixture of polyvinyl alcohol (PNA) with a mass of 72000, at a concentration of 10 - 12% and pulverised bacterial cellulose at 0J2 - 12%.
29. A method according to Claim 28, characterised in that the mixture is cryo-gelled into spherical forms through repetitive freezing at temperatures between -17 and -25°C and defrosting at ca. 20°C, in vegetable oil.
30. A method of producing immobilised biocatalysts, characterised in that the bacterial cellulose synthesized by the isolated strain of Acetobacter xylinum, P3o, belonging to the genus Acetobacter, in a stationary culture, is used to produce a carrier to immobilise the yeast Saccharomyces cerevisiae and the bacteria Bacillus subtilis.
31. A method according to Claim 30, characterised in that the bacterial cellulose is synthesized in a liquid medium containing 10 - 30 parts glucose, 10 - 30 parts com steep liquor, 5 - 15 parts ethanol, at a temperature of 27 - 33°C over 5 - 10 days, and subsequently cleaned with 1 - 3% ΝaOH at a temperature of 80-100°C, for 30-120 min and rinsed with water.
32. An application of bacterial cellulose produced in a stationary culture of an Acetobacter xylinum strain as a wound dressing, particularly for bums and surgical wounds.
33. An application according to Claim 32, characterised in that the bacterial cellulose is used in the form of cellulose membranes of arbitrary shape and size.
34. An application according to Claim 32, characterised in that dressings made of bacterial cellulose secure the surface of wounds against excessive extranefrous water loss.
35. An application according to claim 32, characterised in that bacterial cellulose dressings ensure a moist environment and seal the surface of the wound.
36. An application according to Claim 32, characterised in that modified celulose material is used.
37. A method of modifying cellulose membranes, characterised in that it consists of the selective oxidation of bacterial cellulose using oxidative agents.
38. A method according to Claim 37, characterised in that cellulose membranes are produced in the presence of CMC.
39. A method of modifying cellulose membranes, characterised in that it consistes of saturating the membrane with a solution of 1-6 % glycerol, 0,5 - 4 % PEG 400, 0,01 - 1% chlorohexidine.
40. A method of modifying cellulose membranes, characterised in that it consists of the production of composites consisting of cellulose and monomers and/or polimers and/or nano fibres and/or textiles during culturing.
41. A method according to Claim 40, characterised in that the composite is the additional binding agent for bioactive substances promoting healing.
42. A method according to Claim 40, characterised in that the composite increases the pressure applied to the wound.
43. A method according to Claim 40, characterised in that the composite elongates the drying- out time of the dressing.
PCT/PL2004/000051 2003-07-03 2004-07-02 A method for the production of bacterial cellulose WO2005003366A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP04748875A EP1660670A1 (en) 2003-07-03 2004-07-02 A method for the production of bacterial cellulose

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PL361067A PL212003B1 (en) 2003-07-03 2003-07-03 Method for obtaining bacterial cellulose, method for bacteria immobilization, method for obtaining immobilized biocatalysts, application of bacterial cellulose, method for modification of cellulose membranes
PLP361067 2003-07-03

Publications (1)

Publication Number Publication Date
WO2005003366A1 true WO2005003366A1 (en) 2005-01-13

Family

ID=33563109

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/PL2004/000051 WO2005003366A1 (en) 2003-07-03 2004-07-02 A method for the production of bacterial cellulose

Country Status (3)

Country Link
EP (1) EP1660670A1 (en)
PL (1) PL212003B1 (en)
WO (1) WO2005003366A1 (en)

Cited By (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007091801A1 (en) * 2006-02-07 2007-08-16 Natural F & P Corp. A sheet device comprising bio-cellulose for alleviating skin damage and relieving skin problem
WO2007106251A1 (en) * 2006-03-13 2007-09-20 Xylos Corporation Oxidized microbial cellulose and use thereof
CN100365128C (en) * 2006-01-24 2008-01-30 李胜 Method for preparing bacteria cellulose
WO2008081349A1 (en) * 2006-12-29 2008-07-10 Medestea Research & Production S.P.A. Process for producing a cellulose-based film to be used for skin and tissue lesions
EP1953174A1 (en) * 2007-01-31 2008-08-06 Xylos Corporation Oxidized microbial cellulose and use thereof
CN101979636A (en) * 2010-11-05 2011-02-23 钟春燕 Method for preparing spherical bacterial cellulose
CN102091346A (en) * 2010-01-15 2011-06-15 东华大学 Bacterial cellulose-based antibacterial dry film for acute trauma and preparation method and application thereof
CN102146167A (en) * 2010-12-21 2011-08-10 东华大学 Method for loading oil soluble additive into bacterial cellulose
EP2371401A2 (en) 2010-03-08 2011-10-05 Politechnika Lodzka A method of production of a cartilage-like biomaterial designed for reconstructive surgery
CN102631697A (en) * 2012-05-10 2012-08-15 贾国平 Preparation and test method of magnesium sulfate dried piece
CN102671236A (en) * 2012-05-03 2012-09-19 北京科技大学 Method for preparing nanofiber reinforcement hydrogel bionic artificial meniscus composite material
CN103060229A (en) * 2012-12-19 2013-04-24 华南理工大学 gloconacetobacter xylinum and method for fermenting high-yield bacterial celluloses through mixed flora
CN103120803A (en) * 2012-12-29 2013-05-29 钟春燕 Preparation method of bacterial cellulose composite chitosan moist antimicrobial dressing
CN103212106A (en) * 2013-04-18 2013-07-24 钟春燕 Method for preparing bacterial cellulose slow-release analgesia dressing
US20140024075A1 (en) * 2012-05-15 2014-01-23 Shanghai Zhiyi Information Technology Ltd. Bacterial culture media and methods for their preparation and use
CN104225669A (en) * 2014-08-25 2014-12-24 华南理工大学 Bioactive bacterial cellulose-zein composite film and preparation method thereof
US8951551B2 (en) 2005-08-31 2015-02-10 Board Of Regents, The University Of Texas System Multiribbon nanocellulose as a matrix for wound healing
CN104436291A (en) * 2014-11-17 2015-03-25 江南大学 Cowherb seed flavonoid glycoside/bacterial cellulose dressing for treating diabetic foot ulcers and preparation method thereof
CN104928330A (en) * 2015-07-06 2015-09-23 青海威德生物技术有限公司 Fructo-oligosaccharide producing method with fossilized endoinulinase in bacterial cellulose
CN107557400A (en) * 2017-10-12 2018-01-09 东北电力大学 A kind of method for improving corn stalk hydrolysis culture saccharomyces oleaginosus oil production
CN108579436A (en) * 2018-04-28 2018-09-28 蒋春霞 A kind of preparation method of gradient duct carbon microfiltration membrane
CN108823257A (en) * 2018-06-20 2018-11-16 齐齐哈尔龙江阜丰生物科技有限公司 The preparation process of Threonine Fermentation culture medium
CN109468746A (en) * 2018-12-14 2019-03-15 金华天晟合纤科技有限公司 A kind of high-biocompatibility spunlace non-woven cloth
CN109529092A (en) * 2018-11-26 2019-03-29 福建卫生职业技术学院 A kind of moist antiseptic dressing of bacteria cellulose-base and preparation method
US10253347B2 (en) 2015-11-19 2019-04-09 Samsung Electronics Co., Ltd. Method of screening for microorganism having enhanced cellulose productivity
CN109925299A (en) * 2019-04-19 2019-06-25 广东泰宝医疗科技股份有限公司 A kind of preparation method of long-acting temperature-reducing paste of bringing down a fever
CN110699414A (en) * 2019-11-05 2020-01-17 东北农业大学 Method for preparing bacterial cellulose membrane by using enzymatic soybean hydrolysate
CN110951802A (en) * 2018-09-26 2020-04-03 中国科学院青岛生物能源与过程研究所 Preparation method of functional bacterial cellulose
CN112011581A (en) * 2019-05-30 2020-12-01 华东师范大学 Method for rapidly fermenting uniform bacterial cellulose membrane and application thereof
CN112899324A (en) * 2021-01-29 2021-06-04 北京诺康达医药科技股份有限公司 Bacterial cellulose membrane, breast patch and preparation method thereof
CN112920973A (en) * 2021-03-22 2021-06-08 广西壮族自治区兽医研究所 Bacillus subtilis GL-4 for producing cellulase and application thereof
WO2021236024A1 (en) * 2020-05-21 2021-11-25 Ptt Public Company Limited Preparation of biocellulose wound dressing comprising honey as an antimicrobial active ingredient
US11298225B2 (en) 2018-05-23 2022-04-12 Biotronik Ag Medical implant with seamlessly connected bacterial cellulose
CN115382005A (en) * 2021-05-24 2022-11-25 海南光宇生物科技有限公司 Antibiotic-free medical biological cellulose antibacterial dressing

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101053674B (en) * 2007-05-17 2010-11-24 山东轻工业学院 Method for preparing artificial dura meter of brain using with bacterial cellulose
CN102100365B (en) * 2010-12-21 2012-09-19 东华大学 Production method of colored coconut with high color fastness
CN102146166B (en) * 2010-12-21 2012-08-08 东华大学 Method for loading oil soluble additive into bacterial cellulose
US10709820B2 (en) 2014-11-24 2020-07-14 Biotronik Ag Method for producing a storable molded body made of bacterial cellulose
CN111359007B (en) * 2020-03-23 2022-01-11 瑞希(重庆)生物科技有限公司 Modified bacterial cellulose hydrogel dressing and preparation method thereof
WO2023089010A1 (en) 2021-11-17 2023-05-25 Biotronik Ag Bacterial nanocellulose and method for making the same

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0346507A1 (en) * 1987-03-06 1989-12-20 Board Of Regents, The University Of Texas System Microbial cellulose modified during synthesis

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0346507A1 (en) * 1987-03-06 1989-12-20 Board Of Regents, The University Of Texas System Microbial cellulose modified during synthesis

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
KRYSTYNOWICZ A ET AL: "Factors affecting the yield and properties of bacterial cellulose", JOURNAL OF INDUSTRIAL MICROBIOLOGY AND BIOTECHNOLOGY, vol. 29, no. 4, October 2002 (2002-10-01), pages 189 - 195, XP008037200, ISSN: 1367-5435 *
KRYSTYNOWICZ A ET AL: "THE EVALUATION OF USEFULNESS OF MICROBIAL CELLULOSE AS A WOUND DRESSING MATERIAL", MEDEDELINGEN VAN DE FACULTEIT LANDBOUWWETENSCHAPPEN UNIVERSITEIT GENT, GENT, BE, vol. 65, no. 3A, 2000, pages 213 - 220, XP009032540, ISSN: 0368-9697 *
See also references of EP1660670A1 *
SERAFICA G ET AL: "Inclusion of solid particles in bacterial cellulose", APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, vol. 58, no. 6, May 2002 (2002-05-01), pages 756 - 760, XP002301763, ISSN: 0175-7598 *
SZCZESNA-ANTCZAK M ET AL: "Bacillus subtilis cells immobilised in PVA-cryogels", BIOMOLECULAR ENGINEERING, ELSEVIER, NEW YORK, NY, US, vol. 17, no. 2, January 2001 (2001-01-01), pages 55 - 63, XP004257826, ISSN: 1389-0344 *

Cited By (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8951551B2 (en) 2005-08-31 2015-02-10 Board Of Regents, The University Of Texas System Multiribbon nanocellulose as a matrix for wound healing
CN100365128C (en) * 2006-01-24 2008-01-30 李胜 Method for preparing bacteria cellulose
WO2007091801A1 (en) * 2006-02-07 2007-08-16 Natural F & P Corp. A sheet device comprising bio-cellulose for alleviating skin damage and relieving skin problem
WO2007106251A1 (en) * 2006-03-13 2007-09-20 Xylos Corporation Oxidized microbial cellulose and use thereof
JP2009530440A (en) * 2006-03-13 2009-08-27 ザイロス コーポレイション Oxidized microbial cellulose and uses thereof
US7709631B2 (en) 2006-03-13 2010-05-04 Xylos Corporation Oxidized microbial cellulose and use thereof
CN101611149B (en) * 2006-12-29 2014-03-05 梅迪斯蒂研究及生产股份有限公司 Process for producing cellulose-based film to be used for skin and tissue lesions
WO2008081349A1 (en) * 2006-12-29 2008-07-10 Medestea Research & Production S.P.A. Process for producing a cellulose-based film to be used for skin and tissue lesions
EP1953174A1 (en) * 2007-01-31 2008-08-06 Xylos Corporation Oxidized microbial cellulose and use thereof
CN102091346A (en) * 2010-01-15 2011-06-15 东华大学 Bacterial cellulose-based antibacterial dry film for acute trauma and preparation method and application thereof
EP2371401A2 (en) 2010-03-08 2011-10-05 Politechnika Lodzka A method of production of a cartilage-like biomaterial designed for reconstructive surgery
CN101979636A (en) * 2010-11-05 2011-02-23 钟春燕 Method for preparing spherical bacterial cellulose
CN102146167B (en) * 2010-12-21 2012-07-25 东华大学 Method for loading oil soluble additive into bacterial cellulose
CN102146167A (en) * 2010-12-21 2011-08-10 东华大学 Method for loading oil soluble additive into bacterial cellulose
CN102671236B (en) * 2012-05-03 2014-10-15 北京科技大学 Method for preparing nanofiber reinforcement hydrogel bionic artificial meniscus composite material
CN102671236A (en) * 2012-05-03 2012-09-19 北京科技大学 Method for preparing nanofiber reinforcement hydrogel bionic artificial meniscus composite material
CN102631697A (en) * 2012-05-10 2012-08-15 贾国平 Preparation and test method of magnesium sulfate dried piece
US9708580B2 (en) * 2012-05-15 2017-07-18 Shanghai Zhiyi Information Technology Ltd. Bacterial culture media and methods for their preparation and use
US20140024075A1 (en) * 2012-05-15 2014-01-23 Shanghai Zhiyi Information Technology Ltd. Bacterial culture media and methods for their preparation and use
CN103060229A (en) * 2012-12-19 2013-04-24 华南理工大学 gloconacetobacter xylinum and method for fermenting high-yield bacterial celluloses through mixed flora
CN103060229B (en) * 2012-12-19 2014-09-10 华南理工大学 gloconacetobacter xylinum and method for fermenting high-yield bacterial celluloses through mixed flora
CN103120803A (en) * 2012-12-29 2013-05-29 钟春燕 Preparation method of bacterial cellulose composite chitosan moist antimicrobial dressing
CN103212106A (en) * 2013-04-18 2013-07-24 钟春燕 Method for preparing bacterial cellulose slow-release analgesia dressing
CN104225669A (en) * 2014-08-25 2014-12-24 华南理工大学 Bioactive bacterial cellulose-zein composite film and preparation method thereof
CN104436291A (en) * 2014-11-17 2015-03-25 江南大学 Cowherb seed flavonoid glycoside/bacterial cellulose dressing for treating diabetic foot ulcers and preparation method thereof
CN104928330A (en) * 2015-07-06 2015-09-23 青海威德生物技术有限公司 Fructo-oligosaccharide producing method with fossilized endoinulinase in bacterial cellulose
US10253347B2 (en) 2015-11-19 2019-04-09 Samsung Electronics Co., Ltd. Method of screening for microorganism having enhanced cellulose productivity
CN107557400A (en) * 2017-10-12 2018-01-09 东北电力大学 A kind of method for improving corn stalk hydrolysis culture saccharomyces oleaginosus oil production
CN107557400B (en) * 2017-10-12 2022-05-31 东北电力大学 Method for improving oil production of grease yeast cultured by corn straw hydrolysate
CN108579436A (en) * 2018-04-28 2018-09-28 蒋春霞 A kind of preparation method of gradient duct carbon microfiltration membrane
US11298225B2 (en) 2018-05-23 2022-04-12 Biotronik Ag Medical implant with seamlessly connected bacterial cellulose
CN108823257A (en) * 2018-06-20 2018-11-16 齐齐哈尔龙江阜丰生物科技有限公司 The preparation process of Threonine Fermentation culture medium
CN110951802B (en) * 2018-09-26 2022-09-06 中国科学院青岛生物能源与过程研究所 Preparation method of functional bacterial cellulose
CN110951802A (en) * 2018-09-26 2020-04-03 中国科学院青岛生物能源与过程研究所 Preparation method of functional bacterial cellulose
CN109529092A (en) * 2018-11-26 2019-03-29 福建卫生职业技术学院 A kind of moist antiseptic dressing of bacteria cellulose-base and preparation method
CN109468746A (en) * 2018-12-14 2019-03-15 金华天晟合纤科技有限公司 A kind of high-biocompatibility spunlace non-woven cloth
CN109468746B (en) * 2018-12-14 2021-07-27 浙江天晟合纤科技股份有限公司 High-biocompatibility spunlace non-woven fabric
CN109925299A (en) * 2019-04-19 2019-06-25 广东泰宝医疗科技股份有限公司 A kind of preparation method of long-acting temperature-reducing paste of bringing down a fever
CN112011581A (en) * 2019-05-30 2020-12-01 华东师范大学 Method for rapidly fermenting uniform bacterial cellulose membrane and application thereof
CN110699414A (en) * 2019-11-05 2020-01-17 东北农业大学 Method for preparing bacterial cellulose membrane by using enzymatic soybean hydrolysate
WO2021236024A1 (en) * 2020-05-21 2021-11-25 Ptt Public Company Limited Preparation of biocellulose wound dressing comprising honey as an antimicrobial active ingredient
CN112899324A (en) * 2021-01-29 2021-06-04 北京诺康达医药科技股份有限公司 Bacterial cellulose membrane, breast patch and preparation method thereof
CN112899324B (en) * 2021-01-29 2022-07-01 北京诺康达医药科技股份有限公司 Bacterial cellulose membrane, breast patch and preparation method thereof
CN112920973A (en) * 2021-03-22 2021-06-08 广西壮族自治区兽医研究所 Bacillus subtilis GL-4 for producing cellulase and application thereof
CN115382005A (en) * 2021-05-24 2022-11-25 海南光宇生物科技有限公司 Antibiotic-free medical biological cellulose antibacterial dressing

Also Published As

Publication number Publication date
PL361067A1 (en) 2005-01-10
EP1660670A1 (en) 2006-05-31
PL212003B1 (en) 2012-07-31

Similar Documents

Publication Publication Date Title
WO2005003366A1 (en) A method for the production of bacterial cellulose
Zhong Industrial-scale production and applications of bacterial cellulose
Ha et al. Bacterial cellulose production from a single sugar α-linked glucuronic acid-based oligosaccharide
Ullah et al. Synthesis, structure, and properties of bacterial cellulose
Mohammad et al. An overview of biocellulose production using Acetobacter xylinum culture
Lustri et al. Microbial cellulose—biosynthesis mechanisms and medical applications
Bagewadi et al. Statistical optimization and characterization of bacterial cellulose produced by isolated thermophilic Bacillus licheniformis strain ZBT2
JP6441680B2 (en) Matrix and composition for microbial culture of Gram positive bacteria
Raghavendran et al. Bacterial cellulose: Biosynthesis, production, and applications
Avcioglu Bacterial cellulose: Recent progress in production and industrial applications
Niyazbekova et al. An overview of bacterial cellulose applications
Foresti et al. Bacterial nanocellulose: Synthesis, properties and applications
KR101834169B1 (en) Manifacturing method of dried bio-cellulose for mask pack sheet
CN104784739B (en) A kind of preparation method for carrying flamazine compound antiseptic dressing
Keshk et al. Natural bacterial biodegradable medical polymers: Bacterial cellulose
Nicomrat Silver Nanoparticles Impregnated Biocellulose Produced by Sweet Glutinous Rice Fermentation with the Genus Acetobacter
CN110283730B (en) Process for embedding composite microecological preparation by solution blending method
Amr et al. Bacterial Cellulose: Biosynthesis and Applications
CN110507848B (en) Enzyme-loaded bacterial cellulose-based composite antibacterial hydrogel dressing and preparation method thereof
CN112791100A (en) Composite antibacterial microsphere with efficient active oxygen scavenging function and preparation method thereof
JPH05252970A (en) Production of alginic acid oligosaccharide having bacteriostatic action and bacteriostatic agent containing the substance as active component
Han et al. Bacterial cellulose and its applications
CN114438067B (en) Method for fixing microorganism to produce hyaluronic acid in high yield by using 3D printing technology
Atiq et al. Production and Synthesis of Bacterial Cellulose and Its Applications: A Review
Quintana-Quirino et al. Microbial cellulose: biosynthesis and textile applications

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DPEN Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2004748875

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2004748875

Country of ref document: EP